Search in:

Advanced search

Scandinavian Journal of Infectious Diseases Volume 14, 1982 - Issue sup36

Submit an article Journal homepage

125

Views

CrossRef citations to date

Altmetric

Miscellany

Positions in Infectious and Parasitic Diseases: Excerpts from the 8th IFIPD Congress Stockholm, June 8–11, 1982

Sven Britton

Pages 1-156 | Published online: 02 Jan 2015

Cite this article
https://doi.org/10.3109/inf.1982.14.suppl-36.01

References
Citations
Metrics
Reprints & Permissions

References

Special Programme for Research and Training in Tropical Diseases. Fifth Annual Report 1980–1981.
Google Scholar
Godfrey, D. G.: Identification of economically important parasites. Nature 273: 600, 1978
PubMed Web of Science ®Google Scholar
Miles, M. A., : Do radically disimilar Trypanosoma Cruzi strains (Zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease. Lancet 1: 1338, 1981
PubMed Web of Science ®Google Scholar

References

Epstein, M. A. & Achong, B. G.: Epstein-Barr virus, malaria and Burkitt's lymphoma. The Epstein-Barr Virus. Springer-Verlag. Berlin and New York 1979
Google Scholar
Klein, G.: Introduction to “Viral Oncology”, pp. V–IX. Raven Press, N.Y. 1980
Google Scholar
Yefenof, E., Klein, G., Mondal, M. & Oldstone, M. B. A.: Surface markers on human B- and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines. Int J Cancer 17: 693–700, 1976
PubMed Web of Science ®Google Scholar
Jondal, M., Klein, G., Oldstone, M. B. A., Bokish, V. & Yefenof, E.: Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol 5: 401–410, 1976
PubMed Web of Science ®Google Scholar
Klein, G., Yefenof, E., Falk, K. & Westman, A.: Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma. Int J Cancer 21: 552–560, 1978
PubMed Web of Science ®Google Scholar
Graessman, A., Wolf, H. & Bornkam, G. W.: Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci 77: 433–436, 1980
PubMed Web of Science ®Google Scholar
Volsky, D. J., Shapiro, I. M. & Klein, G.: Transfer of Epstein-Barr virus receptors in receptor-negative cells permits virus penetration and antigen expression. Proc Natl Acad Sci 77: 5453–5457, 1980
PubMed Web of Science ®Google Scholar
Reedman, B. M. & Klein, G.: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11: 499–520, 1973
PubMed Web of Science ®Google Scholar
Einhorn, L. & Ernberg, I.: Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes. Int J Cancer 21: 157–160, 1978
PubMed Web of Science ®Google Scholar
Miller, G.: Biology of Epstein-Barr virus. In: Viral oncology ed. G. Klein), pp. 713–738. Raven Press, New York 1980
Google Scholar
Nilsson, K. & Pontén, J.: Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15: 321–341, 1975
PubMed Web of Science ®Google Scholar
Hausen zur, H.: Oncogenic herpesviruses. Biochim Biophys Acta 447: 25–53, 1975
Google Scholar
Adams, A. & Lindahl, T.: Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72: 1477–1481, 1975
PubMed Web of Science ®Google Scholar
Adams, A.: Molecular biology of the Epstein-Barr virus. In: Viral oncology ed. G. Klein), pp. 683–711. Raven Press, New York 1980
Google Scholar
Klein, G., Dombos, L. & Gothoskar, B.: Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer 10: 44–57, 1972
PubMed Web of Science ®Google Scholar
Gerber, P.: Activation of Epstein-Barr virus by 5-bromodeoxyuridine in “virus-free” human cells. Proc Natl Acad Sci 69: 83–85, 1972
PubMed Web of Science ®Google Scholar
Hampar, B., Berge, J. G., Martos, I. M. & Walter, J. L.: Synthesis of Epstein-Barr virus after activation of the viral genome in a “virus negative” human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine. Proc Natl Acad Sci 69: 78–82, 1982
Google Scholar
Yamamoto, N. & Hausen, H. Zur.: Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature 280: 244–245, 1979
PubMed Web of Science ®Google Scholar
Luka, J., Kallin, B. & Klein, G.: Induction of the Epstein-Barr (EBV) cycle in latently infected cells by n-butyrate. Virology 94: 228–231, 1979
PubMed Web of Science ®Google Scholar
Tovey, M. C., Lenoir, G. & Begon-Lours, J.: Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276: 270–272, 1978
PubMed Web of Science ®Google Scholar
Ben-Sasson, S. & Klein, G.: Activation of the Epstein-Barr virus genome by 5-aca-zytidine in latently infected human lymphoid lines. Int J Cancer 28: 131–135, 1981
PubMed Web of Science ®Google Scholar
Zeuthen, J. & Klein, G.: B-cell and Epstein-Barr virus (EBV) associated functions in human cells and hybrids. In: Transfer of cell constituents into eukaryotic cells. NATO advanced study inst. series A, vol. 31 ed. J. E. Celis, A. Graessman & A. Loyter), pp. 235–273. Plenum Press, N.Y. 1980
Google Scholar
Neubauer, R. H., Rabin, H., Strand, B. C., Nonoyama, M. & Nelson-Ress, W. A.: Establishment of a lymphoblastoid cell line and isolation of an Epstein-Barr-related virus of gorilla origin. J Virol 31: 845–848, 1979
PubMed Web of Science ®Google Scholar
Rabin, H., Neubauer, R. H. & Hopkins, F.: In vitro lymphocyte transformation by Epstein-Barr virus (EBV)-like virus isolated from old-world non-human primates. IARC Sci Publ 24, pp. 553–557, 1978
Google Scholar
Ohno, S., Luka, J., Falk, L. & Klein, G.: Serological reactivities of human and baboon sera against EBNA and Herpesvirus papio-determined nuclear antigen (HUPNA). Eur J Cancer 14: 955–960, 1978
Web of Science ®Google Scholar
Falk, L., Henle, G., Henle, W., Deinhardt, F. & Schudel, A.: Transformation of lymphocytes by herpesvirus papio. Int J Cancer 20: 219–226, 1977
PubMed Web of Science ®Google Scholar
Falk, L., Lindahl, T. & Klein, G.: Herpesvirus papio: State of viral DNA in baboon lymphoblastoid cell lines. In: Oncogenesis and Herpesviruses. III. Proc. of the Third Int. Symp. on Oncogenesis and Herpesviruses held in Cambridge, Mass., USA ed. G. de Thé, W. Henle & F. Rapp), pp. 131–135. Lyon 1978
Google Scholar
Fleckenstein, B. & Mulder, C.: Molecular biological aspects of herpesvirus saimiri and herpesvirus ateles. In: Viral oncology ed. G. Klein), pp. 799–812. Raven Press, N.Y. 1980
Google Scholar
Nilsson, K., Giovanella, B. C., Stehlin, J. S. & Klein, G.: Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 19: 337–344, 1977
PubMed Web of Science ®Google Scholar
Giovanella, B. C., Nilsson, K., Zech, L., Yim, O., Klein, G. & Stehlin, J. S.: Growth of diploid, Epstein-Barr virus carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions. Int J Cancer 24: 103–113, 1979
PubMed Web of Science ®Google Scholar
Povlsen, C. O., Fialkow, P. J., Klein, E., Klein, G., Rygaard, J. & Wiener, F.: Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer 11: 30–39, 1973
PubMed Web of Science ®Google Scholar
Henle, G., Henle, W. & Diehl, V.: Relation of Burkitt's tumor-associated herpes type virus to infectious mononucleosis. Proc Natl Acad Sci 59: 94–101, 1968
PubMed Web of Science ®Google Scholar
Klein, G., Svedmyr, E., Jondal, M. & Persson, P. O.: EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer 17: 21–26, 1976
PubMed Web of Science ®Google Scholar
Robinson, J., Smith, D. & Niederman, J.: Mitotic EBNA positive lymphocytes in peripheral blood during infectious mononucleosis. Nature 287: 334–335, 1980
PubMed Web of Science ®Google Scholar
Britton, S., Andersson-Anvret, M., Gergely, P., Henle, W., Jondal, M., Klein, G., Sandstedt, B. & Svedmyr, E.: Epstein-Barr virus immunity and tissue distribution in a fatal case of infectious mononucleosis. New Engl J Med 298: 89–92, 1978
PubMed Web of Science ®Google Scholar
Svedmyr, E., Jondal, M., Henle, W., Weiland, O., Rombo, L. & Klein, G.: EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. J Clin Lab Immunol 1: 225–232, 1978
PubMedGoogle Scholar
Pattengale, P. K., Smith, R. W. & Perlin, E.: Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers. New Engl J Med 29: 1145–1148, 1974
Google Scholar
Giulano, V. G., Jasin, H. A. & Ziff, M.: The nature of the atypical lymphocyte in infectious mononucleosis. Clin Immunol Immunopathol 3: 90–98, 1974
PubMedGoogle Scholar
Ernberg, R. N., Eberle, B. J. & Williams, C. R., Jr., T and B-cells in peripheral blood during infectious mononucleosis. J Inf Dis 130: 104, 1974
PubMed Web of Science ®Google Scholar
Sheldon, P. J., Papamichael, M., Hemsted, E. H. & Holborow, E. J.: Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet 1: 1153–1155, 1973
PubMed Web of Science ®Google Scholar
Svedmyr, E. & Jondal, M.: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci 72: 1622–1626, 1973
Web of Science ®Google Scholar
Rickinson, A. B., Moss, D. J. & Pope, J. H.: Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. Int J Cancer 23: 610–617, 1979
PubMed Web of Science ®Google Scholar
Moss, D. J., Rickinson, A. B. & Pope, J. H.: Long-term T-cell mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures. Int J Cancer 23: 618–625, 1979
PubMed Web of Science ®Google Scholar
Moss, D. J., Rickinson, A. B. & Pope, J. H.: Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer 22: 662–668, 1978
PubMed Web of Science ®Google Scholar
Masucci, M. G., Masucci, G., Klein, E. & Berthold, W.: Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression. Proc Natl Acad Sci 77: 3620–3624, 1980
PubMed Web of Science ®Google Scholar
Gerber, P.: Definition of infectious and transforming EBV based on known biologic effects in human cells. IARC Sci Publi II, 1975
Google Scholar
Pearson, G., Johansson, B. & Klein, G.: Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngel carcinoma. Int J Cancer 22: 120–125, 1978
PubMed Web of Science ®Google Scholar
Pearson, G. R., Qualtiere, L. F., Klein, G., Norin, T. & Bal, I. S.: Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Int J Cancer 24: 402–406, 1979
PubMed Web of Science ®Google Scholar
Mukojima, T., Gunvén, P. & Klein, G.: Circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma. J Nat Cancer Inst 51: 1319–1321, 1973
PubMedGoogle Scholar
Gunvén, P., Klein, G., Clifford, P. & Singh, S.: Epstein-Barr virus associated membrane-reactive antibodies during long term survival after Burkitt's lymphoma. Proc Natl Acad Sci USA 71: 1422–1426, 1974
PubMedGoogle Scholar
Purtilo, D. T.: Epstein-Barr virus-induced oncogenesis in immune deficient individuals. Lancet 8163: 300–303, 1981
Google Scholar
Saemundsen, A. K., Purtilo, D. T., Sakamoto, K., Sullivan, J. L., Synnerholm, A. C., Hanto, D., Simmons, R., Anvret, M., Collins, R. & Klein, G.: Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res 41: 4237–4242, 1981
PubMed Web of Science ®Google Scholar
Hanto, D. W., Frizzera, G., Purtilo, D. T., Sakamoto, K., Sullivan, J. L., Saemundsen, A. K., Klein, G., Simmons, R. L. & Najarian, J. S.: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41: 4253–4261, 1981
PubMed Web of Science ®Google Scholar
Saemundsen, A. K., Berkel, A. I., Henle, W., Henle, G., Anvret, M., Sanal, Ö., Ersoy, F., Caglar, M. & Klein, G., Epstein-Barr-virus-carrying lymphoma in a patient with ataxia telangiectasia. Br Med J 282: 425–427, 1981
PubMed Web of Science ®Google Scholar
Masucci, M. G., Szigeti, R., Ernberg, I., Masucci, G., Klein, G., Chessels, J., Sieff, C., Lie, S., Glomstein, A., Businco, L., Henle, W., Henle, G., Pearson, G., Sakamoto, K. & Purtilo, D. T.: Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Cancer Res 41: 4284–4291, 1981
PubMed Web of Science ®Google Scholar
Masucci, M. G., Szigeti, R., Ernberg, I., Björkholm, M., Mellstedt, H., Henle, G., Henle, W., Pearson, G., Masucci, G., Svedmyr, E., Johansson, B. & Klein, G.: Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus-antibody titers. Cancer Res 41: 4292–4301, 1981
PubMed Web of Science ®Google Scholar
Szigeti, R., Luka, J. & Klein, G.: Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor. Cellular Immunol 58: 269–276, 1981
PubMed Web of Science ®Google Scholar
Szigeti, R., Masucci, M. G., Henle, W., Henle, G., Purtilo, D. T. & Klein, G.: Effect of different Epstein-Barr virus-determined antigens (EBNA, EA and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies. Clin Immunol Immunopathol 22: 128–138, 1982
PubMedGoogle Scholar
Szigeti, R., Volsky, D. J., Luka, J. & Klein, G.: Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors. J Immunol 126: 1676–1679, 1981
PubMed Web of Science ®Google Scholar
Penn, I.: Tumors arising in organ transplant recipients. Adv Cancer Res 28: 31–61, 1978
PubMedGoogle Scholar
Furth, J.: Conditioned and autonomous neoplasms: A review. Cancer Res 13: 477–492, 1953
PubMed Web of Science ®Google Scholar
Klein, G.: The Epstein-Barr virus and neoplasia. New Engl J Med 293: 1353, 1975
PubMed Web of Science ®Google Scholar
Lennert, K.: Malignant lymphomas. Springer-Verlag, Berlin and New York 1978
Google Scholar
Gunvén, P., Klein, G., Klein, E., Norin, T. & Singh, S.: Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients. Int J Cancer 25: 711–719, 1980
PubMed Web of Science ®Google Scholar
van Boxel, J. A. & Buell, D. N.: IgD on cell membranes of human lymphoid cell lines with multiple immunoglobulin classes. Nature 251: 443–444, 1974
PubMed Web of Science ®Google Scholar
Spira, G., Åman, P., Koide, N., Lundin, G., Klein, G. & Hall, K.: Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines. J Immunol 126: 122–126, 1981
PubMed Web of Science ®Google Scholar
Zerbini, M. & Ernberg, I.: Can Epstein-Barr virus infect and transform all the B-lymphocytes of human cord-blood? J Virol (submitted)
Google Scholar
Olweny, Ch. L. M., Atine, I., Kaddu-Mukasa, A., Owor, R., Andersson-Anvret, M., Klein, G., Henle, W. & Thé de, G.: Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda. J Natl Cancer Inst 58: 1191–1196, 1977
PubMedGoogle Scholar
Klein, G.: Studies on the Epstein-Barr virus genome and the EBV-determined nuclear antigen in human malignant disease. Cold Spring Harbor Symp on Quant Biol 39: 783–790, 1975
PubMedGoogle Scholar
Lindahl, T., Klein, G., Reedman, B. M., Johansson, B. & Singh, S.: Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer 13: 764–772, 1974
PubMed Web of Science ®Google Scholar
Hausen zur, H. & Schulte-Holthausen, H.: Presence of EB-virus nucleic acid homology in a “virus-free” line of Burkitt tumour cells. Nature 227: 245–248, 1970
PubMed Web of Science ®Google Scholar
Nonoyama, M., Huang, C. H., Pagano, J. S., Klein, G. & Singh, S.: DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci 70: 3265–3268, 1973
PubMed Web of Science ®Google Scholar
Thé de, G.: Role of Epstein-Barr virus in human disease: Infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma. In: Viral oncology ed. G. Klein), pp. 769–797. Raven Press, N.Y. 1980
Google Scholar
Andersson, M., Klein, G., Ziegner, J. L. & Henle, W.: Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature 260: 357–359, 1976
PubMed Web of Science ®Google Scholar
Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menezes, J., Nilsson, K. & Sundström, Ch.: Continuous lymphoid cell lines with B-cell characteristics that lack the Epstein-Barr virus genome, derived from three human lymphomas. Proc Natl Acad Sci 71: 3283–3286, 1974
PubMed Web of Science ®Google Scholar
Menezes, J., Leibold, W., Klein, G. & Clements, G.: Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJAB) from an exceptional EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22: 276–284, 1975
PubMedGoogle Scholar
Klein, G., Giovanella, B., Westman, A., Stehlin, J. G. & Mumford, D.: An EBV-genome-negative cell line established from an African Burkitt lymphoma; receptor characteristics. EBV infectability and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5: 319–334, 1975
PubMed Web of Science ®Google Scholar
Klein, G. & Lenoir, G.: Translocation of specific chromosome fragments to Ig-locus carrying chromosomes in B-cell derived neoplasia: Alternative model for permanent oncogene activation in tumorigenesis. Advances in Cancer Res (submitted)
Google Scholar
Klein, G.: Herpesviruses and oncogenesis. Nature 252: 348–350, 1974
Web of Science ®Google Scholar
Montagnier, L. & Gruest, J.: Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion. Int J Cancer 23: 71–75, 1979
PubMed Web of Science ®Google Scholar
Steinitz, M. & Klein, G.: Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci 72: 3518–3520, 1975
PubMed Web of Science ®Google Scholar
Steinitz, M. & Klein, G.: Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro. Virology 70: 570–573, 1976
PubMed Web of Science ®Google Scholar
Steinitz, M. & Klein, G.: Superinfection of EBV-carrying lines with herpesvirus papio (HVP): Induction of early antigen (EA) and inhibition of cellular DNA synthesis. Europ J Cancer 15: 217–222, 1979
Web of Science ®Google Scholar

References

Bruce-Chwatt, L. J. (ed.), Black, R. H., Canfield, C. J., Clyde, D. F., Peters, W. & Wernsdorfer, W. H.: Chemotherapy of malaria, 2nd ed. WHO, Geneva, 1981
Google Scholar
Desjardins, R. E., Canfield, C. J., Haynes, J. D. & Chulay, J. D.: Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial agents and chemotherapy 16: 710–718, 1979
PubMed Web of Science ®Google Scholar
Neiva, A.: Über die Bildung einer chininresistenten Rasse des Malariaparasiten. Memorias do Instituto Oswaldo Cruz 2: 131–140, 1910
Google Scholar
Nguyen-Dinh, P. & Payne, D.: Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull WHO 58: 909–912, 1980
PubMed Web of Science ®Google Scholar
Nocht, B. & Werner, H.: Beobachtungen über relative Chininresistenz bei Malaria aus Brasilien. Deutsch Med Wochenschr 36: 1557–1560, 1910
Google Scholar
Richards, W. H. G. & Maples, B. K. Studies on Plasmodium falciparum in continuous cultivation. I. The effect of chloroquine and pyrimethamine on parasite growth and viability. Ann Trop Med Parasitol 73: 99–108, 1979
PubMed Web of Science ®Google Scholar
Schmidt, L. H., Harrison, J., Rossan, R. N., Vaughan, D. & Crosby, R.: Quantitative aspects of pyrimethamine-sulfonamide synergism. Am J Trop Med Hyg 26: 837–849, 1977
PubMed Web of Science ®Google Scholar

References

Sweeney, T. R.: The present status of malaria chemotherapy: Mefloquine, a novel antimalarial. Med Res Rev 1: 281–301, 1981
PubMed Web of Science ®Google Scholar
Rozman, R. S. & Canfield, C. J.: New experimental antimalarial drugs. In: Advances in pharmacology and chemotherapy, vol. 16, pp. 1–43. Academic Press, New York 1979
Google Scholar
Canfield, C. J.: Antimalarial aminoalcohol alternatives to mefloquine. Acta Tropica 37: 232–237, 1980
PubMed Web of Science ®Google Scholar
Sweeney, T. R., Davidson, D. E., Nodiff, E. A., Saggiomo, A. J. & LaMontagne, M. P.: Recent developments in potential 8- and 4-aminoquinoline antimalarial drugs. Int. Symposium on Chemotherapy and Immunology in the Control of Malaria, Filariasis and Leishmaniasis, Lucknow, India, 18–21, Feb. 1981
Google Scholar
Zhang Xiuping, Li Guangyun, Dai Zurui, Qian Yongle & Chen Lin: Studies on antimalarial. III. Synthesis and antimalarial activities of some derivatives of 2,4-diamino-6-substituted piperazinyl quinazolines. Acta Pharm Sinica 16: 415–424, 1981
Google Scholar
Klayman, D. L., Scovill, J. P., Bartosevich, J. F. & Mason, C. J.: 2-Acetylpyridine thiosemicarbazones. 2. N4,N4-disubstituted derivatives as potential antimalarial agents. J Med Chem 22: 1367–1373, 1979
PubMed Web of Science ®Google Scholar
Davidson, D. E., Ager, A. L., Brown, J. L., Chapple, F. E., Whitmire, R. D. & Rossan, R. N.: New tissue schizontocidal antimalarial drugs. Bull WHO 59 (3): 463–479, 1981
PubMed Web of Science ®Google Scholar
Strube, R. E. & LaMontagne, M. P.: 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino) quinoline antimalarials. U.S. Patent Application SN 158, 798, 1980
Google Scholar
Nodiff, E. A. & Saggiomo, A. J.: 5-Alkoxy-8-quino-linamines for the broad-spectrum treatment of malaria. U.S. Patient Application SN 229, 487, 1981
Google Scholar
LaMontagne, M. P., Markovac, A. & Khan, M. S.: Antimalarials 13. 5-Alkoxy analogs of 4-methylprimaquine. J. Med Chem 25: 964–968, 1982
Web of Science ®Google Scholar
LaMontagne, M. P., Strube, R. E. & Blumbergs, P.: Antimalarials 14. 5-Aryloxy-4-methylprimaquine analogs, a highly effective series of blood and tissue schizontocidal agents. J Med Chem 25: 1094–1097, 1982
PubMed Web of Science ®Google Scholar
Nodiff, E. A., Tanabe, K., Chen, E. H. Saggiomo, A. J.: Modifications of primaquine as antimalarials. 3. 5-Phenoxy derivatives of primaquine. J Med Chem 25: 1097–1101, 1982
PubMed Web of Science ®Google Scholar

Reference

Jaywardena, A. N.: Immune responses in malaria. In: Parasitic diseases ed. J. M. Mansfield). Marcel Kekker Inc., 1981
Google Scholar

References

Aikawa, M., Yoshida, N., Nussenzweig, R. S. & Nussenzweig, V.: The protective antigen of rodent malarial sporozoites (Plasmodium berghei) is a differentiation antigen. J Immunol 126: 2494, 1981
PubMed Web of Science ®Google Scholar
Carter, R. & Gwadz, R. W.: Infectiousness and gamete immunization. In: Malaria, vol. 3 ed. J. P. Kreier), pp. 263–293. Academic Press, New York 1980
Google Scholar
Cochrane, A. H., Nussenzweig, R. S. & Nardin, E. H.: Immunization against sporozoites. In: Malaria, vol. 3 ed. J. P. Kreier) pp. 163–197. Academic Press, New York 1980
Google Scholar
Cochrane, A. H., Santoro, F., Nussenzweig, V., Gwadz, R. & Nussenzweig, R. S.: Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci 79 (18): 5651, 1982
PubMed Web of Science ®Google Scholar
Cohen, S.: Progress in malaria vaccine development. Br Med Bull 38: 161, 1982
PubMed Web of Science ®Google Scholar
Epstein, N., Miller, L. H., Kaushel, D. C., Udeniya, I. J., Rener, J., Howard, R. J., Asofsy, R., Aikawa, M. & Hess, R. L.: Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocytic invasion. J Immunol 127: 212, 1981
PubMed Web of Science ®Google Scholar
Freeman, R. F., Trejdosiewicz, A. J. & Cross, G.: Protective monoclonal antibodies recognizing stage-specific merozoite antigens of rodent malaria parasites. Nature 284: 366, 1980
PubMed Web of Science ®Google Scholar
Gwadz, R. W. & Green, I.: Malaria immunization in rhesus monkeys: A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi. J Exp Med 148: 1311, 1978
PubMed Web of Science ®Google Scholar
Holder, A. A. & Freeman, R. R.: Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 294: 364, 1981
PubMed Web of Science ®Google Scholar
Hollingdale, M. R., Zavala, F., Nussenzweig, R. S. & Nussenzweig, V.: Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. J Immunol 128: 1929, 1982
PubMed Web of Science ®Google Scholar
Kilejian, A.: Histidine-rich protein as a model malaria vaccine. Science 201: 922, 1978
PubMed Web of Science ®Google Scholar
Köhler, G. & Milstein, C.: Continous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495, 1975
PubMed Web of Science ®Google Scholar
Lambros, C. & Vanderberg, J. P.: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418, 1979
PubMed Web of Science ®Google Scholar
Lerner, R. A., Green, N., Olson, A., Shinnick, T. & Sutcliffe, J. G.: The development of synthetic vaccines. Hosp Practice 16: 55, 1981
Web of Science ®Google Scholar
Mendis, K. N. & Targett, G. A. T.: Immunization against gametes and asexual erythrocytic stages of a rodent malaria parasite. Nature 277: 389, 1979
PubMed Web of Science ®Google Scholar
Nardin, E. H., Nussenzweig, V., Nussenzweig, R. S., Collins, W. E., Harinasuta, T., Tapachaisri, P. & Chomcharn, Y.: Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 156: 20, 1982
PubMed Web of Science ®Google Scholar
Nussenzweig, R. S.: Use of radiation-attenuated sporozoites in the immunoprophylaxis of malaria. J Nucl Med & Biol 7: 89, 1980
Web of Science ®Google Scholar
Perrin, L. H., Ramirez, E., Lambert, Ph. H. & Miescher, P. A.: Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature 289: 301, 1981
PubMed Web of Science ®Google Scholar
Potocnjak, P., Yoshida, N., Nussenzweig, R. S. & Nussenzweig, V.: Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malaria infection. J Exp Med 151: 1504, 1980
PubMed Web of Science ®Google Scholar
Potocnjak, P., Zavala, F., Nussenzweig, R. S. & Nussenzweig, V.: Inhibition of idiotype-anti-idiotype interaction for detection of a parasite antigen: A new immunoassay. Science 215: 1637, 1982
PubMed Web of Science ®Google Scholar
Rener, J., Carter, R., Rosenberg, Y. & Miller, L. H.: Antigamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito. Proc Natl Acad Sci USA 77: 6797, 1980
PubMed Web of Science ®Google Scholar
Santoro, F., Cochrane, A. H., Nussenzweig, V., Nardin, E. H., Nussenzweig, R. S., Gwadz, R. W. & Ferreira, A.: Structural similarities between the protective antigens of sporozoites from different species of malaria. J Biol Chem 1983 (in press)
Google Scholar
Siddiqui, W. A.: Immunization against asexual blood-inhabiting stages of Plasmodia. In: Malaria, vol. 3 ed. J. P. Kreier) pp. 231–257. Academic Press, New York 1980
Google Scholar
Trager, W. & Jensen, J. B.: Human malaria parasites in continuous culture. Science 193: 643, 1976
Web of Science ®Google Scholar
Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V. & Aikawa, M.: Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207: 71, 1980
PubMed Web of Science ®Google Scholar
Yoshida, N., Potocnjak, P., Nussenzweig, V. & Nussenzweig, R. S.: Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J Exp Med 154: 1225, 1981
PubMed Web of Science ®Google Scholar
Zavala, F., Gwadz, R. W., Collins, F. H., Nussenzweig, R. S. & Nussenzweig, V.: Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes. Nature (London) 299, 1982
Google Scholar

References

Intestinal protozoan and helminthic infections. Techn Rep Ser 666, WHO, Geneva, 1981, 150 pp.
Google Scholar
Lopez, C. E., Dykes, A. C., Juranek, D. D., Sinclair, S. P. : Am J Epidemiol 112: 495–507, 1980
PubMed Web of Science ®Google Scholar
Pawlowsky, Z. S., Kasprzak, W., Koziecka, W. & Lisowska, M.: VIII International Congress on Infections and Parasitic Diseases. Stockholm, 1982, Abstracts, pp. 106–107.
Google Scholar
Stephensen, L. S.: Parasitology 81: 221–233, 1980
PubMed Web of Science ®Google Scholar
Mata, L. G.: Am J Trop Med Hyg 24: 564–575, 1975
PubMed Web of Science ®Google Scholar
Tomkins, A. M., Madic, K. & Ogilvie, B. M.: Gut 18A: 970, 1977
Google Scholar
Tomkins, A. M.: Trans Roy Soc Trop Med Hyg 72: 33–36, 1978
PubMed Web of Science ®Google Scholar
Pavlov, B. A.: (In Russian, with English summary.) Sovetskaya Medicina (7) 143–147, 1963
Google Scholar
Karnauchov, V. K., Faibusovitch, G. M. & Zalnova, N. S.: (In Russian, with English summary.) Sovetskaya Medicina (8), 150–155, 1966
Google Scholar
Plotnikov, N. N., Ozeretskovskaya, N. N., Karnauchov V. K. : (In Russian, with English summary.) Medicinskaya Parasitologija i parasitarnye bolezni 36: 379–384, 1967
Google Scholar
Ozeretskovskaya, N. N.: (In Russian, with English summary.) Vestnik Akademii Medicinskih Nauk SSSR (6), 36–43, 1975
Google Scholar
Ozeretskovskaya, N. N.: (In Russian.) In: Fundamental helminthology (ed. R. S. Schultz & E. V. Gvozdev), pp. 169–214. Nauka, Moscow, 1976
Google Scholar
Pavlov, B. A.: Acute opistorchiasis, 74 pp. (In Russian.) Tomsk, 1979
Google Scholar
Bronstein, A. M.: (In Russian with English summary.) Medicinskaya Parasitologija i parasitarnye bolezni 51 (5): 12–16, 1982
Google Scholar
Marsden, P. D. (Ed.): Intestinal parasites. Clin Gastroenterol 7: 1–243, 1978
Google Scholar
Lazda, V. A.: Fed Proc 39: 125–129, 1980
Google Scholar
Soothill, J. E., Smits, M. D. & Morgan, A. C.: In: Pathogenic processes in parasitic infections (ed. E. K. Taylor & R. Muller), pp. 59–68. Oxford, 1975
Google Scholar
Zubov, N. A. & Shain, A. A.: (In Russian, with English summary.) Voprosy onkologii 17: 34–39, 1971
PubMedGoogle Scholar
Blochin, N. N.: (In Russian, with English summary.) Vestnik Akademii Medicinskih Nauk SSSR (5): 3–9, 1978
Google Scholar
Clinical approach to infection in the compromised host (ed. R. H. Rubin & L. S. Young), 653 pp. Plenum Publ. Corporat., New York, 1981
Google Scholar
Scowden, E. B., Schaffner, W. & Stone, W. J.: Medicine 57: 527–544, 1978
PubMed Web of Science ®Google Scholar
Ito, A.: Exp Parasitol 49: 248–257, 1980
PubMed Web of Science ®Google Scholar
Ozeretskovskaya, N. N.: Clinical aspects of giardiasis. WHO, INT. PAR/WP/80, 13, 11 pp.
Google Scholar
Ruddell, W. S. J., Axon, A. T. R., Findlay, J. M., Bartholomew, B. A. & Hill, M. J.: The Lancet, March 29, 672–675, 1980
Google Scholar
Hopper, R. E., Gesty, C. L. & Davies, W. A.: J Immunol 126: 1052–1058, 1981
PubMed Web of Science ®Google Scholar
Grönneberg, R., Strandberg, K., Stalenheim, G. & Zetterström, O.: Allergy 36: 201–208, 1981
PubMed Web of Science ®Google Scholar
Lang, I., Török, K., Gergely, P., Nekam, K., Petranyi, G. Y.: Scand J Immunol 13: 361–366, 1981
PubMed Web of Science ®Google Scholar
Campbell, W. C. & Blair, L. S.: Exp Parasitol 35: 304–334, 1974
PubMed Web of Science ®Google Scholar
Corba, J. & Spaldonova, R.: Folia Parasitol 24: 135–139, 1977
PubMedGoogle Scholar
Yir, A.: Sakalauskaite. Medicinskaya Parasitologia i Parasitarnye Bolezni 47 (6): 23–28, 1978
Google Scholar
Pereverseva, E. V., Ozeretskovskaya, N. N. & Veretennikova, N. L.: In: Trichinollosis. Proceedings of the Fourth International Conference on Trichinellosis (ed. Ch. W. Kim & Z. S. Pawlowsky)
Google Scholar
Kochetkova, M. N. & Ozeretskovskaya, N. N.: (In Russian, with English summary.) Biochimia 7: 12–18, 1982
Google Scholar
Merzlova, N. B.: (In Russian, with English summary.) Medicinskaya Parasitologia i Parazitarnye Bolezni 51 (5): 17–22, 1982
Google Scholar
Blagov, N. A. & Firsov, V. M.: (In Russian, with English summary.) Medicinskaya Parasitologia i Parazitarnye Bolezni 51 (5): 23–28, 1982
Google Scholar
Kouri, P. & Diaz, Valdes.: Rev Med Trop Parasitol 8: 37–41, 1952
PubMedGoogle Scholar
Senyel, S. C., Sen, P. C., Tiwary, I. C. : Am J Trop Med Hyg 80: 2–8, 1977
Web of Science ®Google Scholar
Research notes. J Parasitology 62: 839–841, 1976
PubMed Web of Science ®Google Scholar
Grove, D. I.: Br J 280: 598–601, 1980
PubMed Web of Science ®Google Scholar
Shad, G. A.: Science 180: 502–504, 1973
PubMed Web of Science ®Google Scholar
Ozeretskovskaya, N. N., Tumolskaya, N. I., Pereverseva, E. V. : (In Russian, with English summary.) Wiad Parasitol (4–5), 577–589, 1975
Google Scholar
Mackenzie, C. D., Preston, P. M. & Ogilvie, B. M.: Nature 276: 826–828, 1978
PubMed Web of Science ®Google Scholar
Huldt, G., Davies, P., Allison, A. C. : Nature 277–214–216, 1979
Google Scholar
Ridley, M. J.: Comment to the S. G. Wright Giardiasis. Trans Roy Soc Trop Med Hyg 73: 511, 1979
Google Scholar
Sellwood, R.: Biochim Biophys Acta 632: 326–335, 1980
PubMed Web of Science ®Google Scholar
Mattern, C. F. T., Keister, D. B. & Natovitz, P. C.: Am J Trop Med Hyg 29: 26–30, 1980
PubMed Web of Science ®Google Scholar
Gerasimova, N. G.: (In Russian, with English summary.) Medicinskaya Parasitologia i Parasitarnye Bolezni 49 (5): 69–72, 1980
Google Scholar
Herzberg, V., Boughter, I. M. & Carlisle, S.: Nature 286–278–281, 1980
Google Scholar
Damian, R. T.: Am Naturalist 98: 129–149, 1964
Web of Science ®Google Scholar
Dineen, J. K.: Nature 197: 471–472
Web of Science ®Google Scholar
Pizza, A., Belevedere, M. C. : In: Histocompatibility testing (ed. Deusset, J. Colombani). Copenhagen, 1972. pp. 73–78
Google Scholar
Greenwood, B. M.: In: Tropical Diseases Research Series, WHO (1), 229–244, 1979
Google Scholar
Robert-Thomson, I. C., Mitchell, G. F. : Gut 21: 397–401, 1980
PubMed Web of Science ®Google Scholar
Unger, B., Mathews, J. D., Tait, B. D. & Cowling, D. C.: Br Med J 282: 768–770, 1981
PubMed Web of Science ®Google Scholar
Sprent, I.: In: Tropical Diseases Research Series, WHO (1), 43–58, 1979
Google Scholar
Warren, K. S.: In: Parasites in the immunized host: mechanism of survival, pp. 243–261. Amsterdam, 1974
Google Scholar
Allison, A. C., Christensen, J., Clark, I. A., Elford, B. C. & Sugui, S. M.: In: Tropical Diseases Research Series, WHO (I), 151–182, 1979
Google Scholar
Ginovker, A. G. & Konovalova, L. A.: (In Russian, with English summary.) Medicinskaya Parasitologija i Parasitarnye Bolezni 50 (2): 35–38, 1981
Google Scholar
Dembinsky, A. B., Johston, L. R. & Castro, G. A.: Am J Trop Med Hyg 28: 854–862, 1979
PubMed Web of Science ®Google Scholar
de Junge, H. R.: Nature 262: 590–593, 1976
Web of Science ®Google Scholar
Kozjuk, P. M.: (In Russian) In: Materialy 2 Vsesojuznogo sjezda protozoologov, Leningrad, 1976, v. 2, pp. 52–53.
Google Scholar
Frazier, F. & Glaser, L.: Ann Rev Biochem 48: 491–523, 1979
PubMed Web of Science ®Google Scholar
Lad, P. M. & Nielsen, T. B.: FEBS Letters 122: 179–183, 1980
PubMed Web of Science ®Google Scholar
Prakah, O.: Concluding remarks on “Symposium on Giardiasis”. Indian Practitioner 23: 177–179, 1970
Google Scholar
Gupta, V. M., Gupta, J. M. & Marwah, S. M.: J Indian Med Assoc 69: 31–33, 1977
PubMedGoogle Scholar
Nurieva, G. B., Podgorodnichenko, V. K. & Ozeretskovskaya, N. N.: (In Russian, with English summary.) Medicinskaya Parasitologija i Parasitarnye Bolezni 48 (5): 47–50, 1979
Google Scholar
Ozeretskovskaya, N. N.: (In Russian, with English summary.) Medicinskaya Parasitologija i Parasitarnye Bolezni 50 (5): 3–10, 1981
Google Scholar
Ozeretskovskaya, N. N.: (In Russian, with English summary.) Medicinskaya Parasitologija i Parasitarnye Bolezni 50(6): 12–18, 1981
Google Scholar

References

Dubini, A.: Nuovo verme intestinal umano (Agchylostoma duodenale) constituente un sesto genere dei nematoidei proprii dell'uomo. Annali Universali di Medicina 106: 5–13, 1843
Google Scholar
Stiles, C. W.: A new species of hookworm (Uncinaria americana) parasitic in man. Am Med 3: 777–778, 1902
Google Scholar
Peters, W. & Gilles, H.: A color atlas of tropical medicine and parasitology. Wolfe Medical Publications, London 1977
Google Scholar
Layrisse, M. & Roche, M.: The relationship between anemia and hookworm infection. Results of surveys of rural Venezuelan populations. Am J Hyg 79: 279–301, 1964
PubMed Web of Science ®Google Scholar
Masuya, T.: Hookworm disease and nutrition. Seminar on parasitic control in the prevention and malnutrition, Tokyo, December 1–5, 1980
Google Scholar
Hayashi, S.: Economic loss from parasites. In: Collected papers on the control of soil-transmitted helminthiases. (The APCO Research group), pp. 337–342, 1980
Google Scholar
Report of a WHO-Expert-Committee: Control of Ascariasis. WHO. Technical Report Series No. 379. Geneva 1967
Google Scholar
Stephenson, L. S., Latham M. C. & Oduori, M.: Costs, prevalence and approaches for control of Ascaris infection in Kenya. J Trop Pediatr 26: 246–263, 1980
Web of Science ®Google Scholar
Van den Bossche, H.: Peculiar targets in anthelmintic chemotherapy. Biochem Pharmacol 29: 1981–1990, 1980
PubMed Web of Science ®Google Scholar
WHO Techn Rep Ser No. 542 (1974)
Google Scholar
Cross, J. H., Singson, C. N., Battad, S. & Basaca-Sevilla, V.: Intestinal capillariasis: Epidemiology, parasitology and treatment. In: Health policies in developing countries (ed. C. Wood and Y. Rue). Royal Society of Medicine. International Congress and Symposium Series, Number 24, pp. 81–87, 1980
Google Scholar
Schmidt, G. D. & Roberts, L. S.: Foundations of parasitology, p. 428. The C. V. Mosby Company, Saint Louis
Google Scholar
Williams, J. F., Lopez Adaros, H. & Trejos, A.: Current prevalence and distribution of hydatidosis with special reference to the Americas. Am J Trop Med Hyg 20: 224–236, 1971
PubMed Web of Science ®Google Scholar
Schantz, P. M. Van den Bossche, H. & Eckert, J.: Chemotherapy for larval echinococcosis in animals and humans: Report of a Workshop. Z Parasitenk 67: 5–26, 1982
PubMed Web of Science ®Google Scholar
Gatti, F., Krubwa, F., Vandepitte, J. & Thienpont, D.: Control of intestinal nematodes in African schoolchildren by the trimestrial administration of levamisole. Ann Soc Belg Méd Trop 52: 19–32, 1972
PubMedGoogle Scholar
Moens, M., Dom, J., Burke, W. E., Schlossberg, S. & Schuermans, V.: Levamisole in Ascariasis. A multicenter controlled evaluation. Am J Trop Med Hyg 27: 897–904, 1978
PubMed Web of Science ®Google Scholar
Miller, M. J., Farahmandian, I., Arfaa, F., Katz, N., Windsor, E. & Bennett, E.: An evaluation of levamisole for treatment of Ascariasis. Southern Med J 71 (2): 137–140, 1978
PubMed Web of Science ®Google Scholar
Kilpatrick, M.: Levamisole compared to mebendazole in the treatment of Ancylostoma duodenale in Egypt. Trans Roy Soc Trop Med Hyg 75: 578–579, 1981
PubMed Web of Science ®Google Scholar
Davis, A.: Drug treatment in intestinal helminthiasis, p. 29. World Health Organization, Geneva, 1973
Google Scholar
Van den Bossche, H., Rochette, F. & Hörig, C.: Mebendazole and related anthelmintics. In: Advances in pharmacology and chemotherapy, vol. 19. Academic Press, New York 1982 (in press)
Google Scholar
Jancloes, M. & Jancloes-Diepart, M.: Campagnes périodiques d'assainissement et de chimiothérapie de masse contre les nematodes intestinaux, appliquées isolement et en combinaison, au Bas Zaire. Ann Soc Belge Méd Trop 61: 111–118, 1981
PubMedGoogle Scholar
Chongsuphajaisiddhi, T., Sabcharoen, A., Attanath, P., Panasoponkul, C. & Radomyos, P.: Treatment of soil-transmitted nematode infections in children with mebendazole. Ann Trop Med Parasitol 72: 59–63, 1978
PubMed Web of Science ®Google Scholar
Stürchler, D., Stahel, E., Saladin, K. & Saladin, B.: Intestinal Parasitoses in eight Liberian settlements: Prevalences and community anthelmintic chemotherapy. Tropenmed Parasit 31: 87–93, 1980
PubMedGoogle Scholar
Yangco, B. G., Klein, T. W., Derensinski, S. C., Vickery, A. C. & Craig, C. P.: Flubendazole and mebendazole in the treatment of Trichuriasis and other helminthiasis. Clinical Therapeutics 4: 285–290, 1981
PubMed Web of Science ®Google Scholar
Cabrera, B. D., Valdez, E. V. & Go, T. G.: Clinical trials of broad spectrum anthelminties against soil-transmitted helminthiasis. Southeast Asian J Trop Med Public Health 11: 502–506, 1980
PubMedGoogle Scholar
Kan-Chua, S. P.: Comparative drug trials on the efficacy of mebendazole and flubendazole in the treatment of Trichuris trichiura and Ascaris lumbricoides infections in children. Symposium on: Progress in anthelmintic therapy, Kuala Lumpur, August, 20, 1980
Google Scholar
Singson, C. N., Banzon, T. C. & Cross, J. H.: Mebendazole in the treatment of intestinal capillariasis. Am J Trop Med Hyg 24: 932–934, 1975
PubMed Web of Science ®Google Scholar
Thienpont, D.: Le traitement de la trichinose. La nouv Presse Méd 5: 1759–1760, 1976
PubMedGoogle Scholar
Sonnet, J. J. & Thienpont, D.: The treatment of trichinosis with mebendazole. Acta Clin Belg 32: 297–302, 1977
PubMed Web of Science ®Google Scholar
Rivas-Alcala, A. R., Taylor, H. R., Ruvalcaba-Macias, A. M., Mackenzie, C. D., Greene, B. M., Domiquez-Vazquez, A., Lugo-Pfeiffer, C. & Beltran-Hernandez, F.: Chemotherapy of onchocerciasis: A controlled comparison of mebendazole, levamisole and diethylcarbamazine. Lancet ii: 485–490, 1981
Google Scholar
Rivas-Alcala, A. R., Greene, B. M., Taylor, H. R., Domiguez-Vaques, A., Ruvalcaba-Macias, A. M., Lugo-Pfeiffer, C. & Beltran-Hernandez, F.: 12-month follow-up of mebendazole therapy for onchocerciasis. Lancet ii: 1043, 1981
Google Scholar
Awadzi, K., Schulz-Key, H., Howells, R. E., Haddock, D. R. W. & Gillis, H. M. The chemotherapy of onchocerciasis VIII. Levamisole and its combination with the benzimidazoles. Ann Trop Med Parasitol 76: 459–473, 1982
PubMed Web of Science ®Google Scholar
Mak, J. W. & Chan, W. C. (submitted to J. Current Med. Res. and Opinion) Treatment of Brugia malayi infection with mebendazole and levamisole.
Google Scholar
Morbidity and Mortality Weekly Report—Centres for Disease Control. 30 (1981): 194–195. (Guinea worm (Dracunculiasis) and the International Water Supply and Sanitation Decade.)
Google Scholar
Gaitonde, B. B. & Renapurkar, D. M.: Report on mebendazole in dracunculiasis. Ethnor-India, 1975
Google Scholar
Werczberger, A., Golham, J., Wertheim, G., Gunders, I. A. E. & Chowers, I.: Disseminated echinococcosis with repeated anaphylactic shock treated with mebendazole. Chest 76: 482–484, 1979
PubMed Web of Science ®Google Scholar
Wilson, J. F. & Rausch, R. L.: Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan eskimos. Am J Trop Med Hyg 29: 1340–1355, 1980
PubMed Web of Science ®Google Scholar
Bekhti, A., Schaaps, J. P., Capron, M. Dessaint, J. P., Santoro, F. & Capron, A.: Treatment of hepatic hydatid disease with mebendazole: Preliminary results in four cases. Br Med J 2: 1047–1051, 1977
PubMed Web of Science ®Google Scholar
Bekhti, A.: Etude séro-immunologique et traitement médical de l'hydatidose humaine. Thesis, University of Liège, Belgium, 1979
Google Scholar
Bryceson, A. D. M., Woestenborghs, R., Michiels, M. & Van den Bossche, H.: Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease. Trans Roy Soc Trop Med Hyg 76: 563–564, 1982
PubMed Web of Science ®Google Scholar

References

Field, M.: Secretion of electrolytes and water by mammalian small intestine. In: Physiology of the gastrointestinal tract, pp. 963–982 (ed. L. R. Johnson). Raven Press, New York 1981
Google Scholar
Freter, R.: Association of enterotoxigenic bacteria with the mucosa of the small intestine: Mechanisms and pathogenic implications. In: Cholera and related diarrheas, pp. 155–170 (ed. Ouchterlony & Ö. J. Holmgren). Karger, Basel 1980
Google Scholar
Holme, T., Holmgren, J., Merson, M. H. & Möllby, R. (eds.): Acute enteric infections in children. New prospects for treatment and prevention. Elsevier/North-Holland Biomedical Press, Amsterdam, New York, Oxford, 1981
Google Scholar
Holmgren, J.: Action of cholera toxin and the prevention and treatment of cholera. Nature (London) 292: 413–417, 1981
PubMed Web of Science ®Google Scholar
Holmgren, J., Lange, S. & Lönnroth, I.: Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine. Gastroenterology 75: 1103–1108, 1978
PubMed Web of Science ®Google Scholar
Holmgren, J., Svennerholm, A.-M. & Lindblad, M.: Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination). Infect Immun (in press 1982)
Google Scholar
Holmgren, J., Fredman, P., Lindblad, M., Svennerholm, A.-M. & Svennerholm, L.: Glycoprotein receptor of rabbit intestine for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (in press 1982)
Google Scholar
Islam, M. R., Sack, D. A., Holmgren, J., Bardhan, P. K. & Rabbani, G. H.: Use of chlorpromazine in the treatment of cholera and other severe acute watery diarrheal diseases. Gastroenterology 82: 1335–1340, 1982
PubMed Web of Science ®Google Scholar
Levine, M. M., Black, R. E., Clements, M. L., Nalin, D. R., Cisneros, L. & Finkelstein, R. A.: Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review. In: Acute enteric infections in children. New prospects for treatment and prevention, pp. 443–459 (ed. T. Holme ). Elsevier/North-Holland Biomedical Press, Amsterdam 1981
Google Scholar
Lönnroth, I., Andrén, B., Lange, S., Martinsson, K. & Holmgren, J.: Chlorpromazine reverses Escherichia coli diarrhea in piglets. Infect Immun 24: 900–908, 1979
PubMed Web of Science ®Google Scholar
Naftalin, R. J.: The role of intracellular calcium in the induction of intestinal secretion. Clin Res Rev 1: (suppl. 1) 63–71. Janssen Pharmaceutical Ltd, Beerse, Belgium 1981
Google Scholar
Pierce, N. F.: The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats. J Exp Med 148: 195–206, 1978
PubMed Web of Science ®Google Scholar
Powell, D. W. & Field, M.: Pharmacological approaches to treatment of secretory diarrhea. In: Secretory diarrhea, pp. 187–209 (ed. M. Field, J. S. Fordtran & S. G. Schultz). Waverly Press, Baltimore 1980
Google Scholar
Rabbani, G. H., Greenough, W. B., Holmgren, J. & Kirkwood, B.: Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously. Br Med J 284: 1361–1364, 1982
PubMed Web of Science ®Google Scholar
Rabbani, G. H., Holmgren, J., Greenough, W. B. & Lönnroth, I.: Chlorpromazine reduces fluid-loss in cholera. Lancet I: 410–412, 1979
Google Scholar
Sack, D. A., Islam, A., Holmgren, J. & Svennerholm, A.-M.: Development of methods for determining the intestinal immune response to V. cholerae antigens in humans. In: Proc. 15th Joint Conference on Cholera. The US-Japan Cooperative Medical Science Program, Cholera Panel, Bethesda, Md, pp. 423–439, NIH Publications, No. 80–2003, 1980
Google Scholar
Stoll, B. J., Holmgren, J., Bardhan, P. K., Greenough, W. B., Huq, I., Fredman, P. & Svennerholm, L.: Binding of intraluminal toxin in cholera: Trial of GM1-ganglioside-charcoal. Lancet II: 888–891, 1980
Google Scholar
Svennerholm, A.-M.: The nature of protective immunity in cholera. In: Cholera and related diarrheas, pp. 171–184 (ed. Ö. Ouchterlony & J. Holmgren). Karger, Basel 1980
Google Scholar
Svennerholm, A.-M., Sack, D. A., Holmgren, J. & Bardhan, P. K.: Intestinal antibody responses after immunization with cholera B subunit. Lancet I: 305–308, 1982
Google Scholar
Svennerholm, A.-M., Jertborn, M., Gothefors, L., Karim, H. A., Sack, D. A. & Holmgren, J.: Secretory immunity to Vibrio cholerae bacteria and cholera toxin: prospects for an improved cholera vaccine. In: Proceedings International Symposium Bacterial Diarrheal Diseases, Osaka. Marcel Dekker, New York (in press 1982)
Google Scholar

References

Salk, J. & Salk, D.: Control of influenza and poliomyelitis with killed virus vaccines. Science 195 (4281): 834–847, 1977
PubMed Web of Science ®Google Scholar
Salk, J.: Persistence of immunity after administration of formalin-treated poliovirus vaccine. Lancet II: 715–723, 1960
Google Scholar
Salk, J., Cohen, H., Fillastre, C., Stoeckel, P., Rey, J.-L., Schlumberger, M., Nicolas, A., van Steenis, G., van Wezel, A. L., Triau, R., Saliou, P., Barry, L. F., Moreau, J.-P. & Merieux, C.: Killed poliovirus antigen titration in humans. Develop Biol Stand 41: 119–132 (S. Karger, Basel), 1978
Google Scholar
Salk, J., van Wezel, A. L., Stoeckel, P., van Steenis, G., Schlumberger, M., Meyran, M., Rey, J.-L., Lapinleimu, K., Bottiger, M. & Cohen, H.: Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. Develop Biol Stand 47: 181–198 (S. Karger, Basel), 1981
Google Scholar
van Wezel, A. L., van der Velden-De Groot, C. A. M. & van Herwaarden, G. A. M.: The production of inactivated polio vaccine on serially cultivated kidney cells from captive-bred monkeys. Develop Biol Stand 46: 151–158, 1980
PubMedGoogle Scholar
Lapinleimu, K., van Wezel, A. L., van Steenis, G., Stenvik, M., Stoeckel, P. & Salk, J.: Effect of interval between first and second doses of killed poliovirus vaccine on degree of antibody response to the second dose. (In preparation.)
Google Scholar
Dick, G. W. A., Dane, D. S., McAlister, J., Briggs, M., Nelson, R. & Field, C. M. B.: Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion. Br Med J 2: 266–269, 1961
PubMed Web of Science ®Google Scholar
Stoeckel, P., : Field studies of the use of DPT-polio vaccine in Senegal. (In preparation.)
Google Scholar
van Wezel, A. L., van der Marel, P., Van Beveren, C. P., Verma, I., Salk, P. & Salk, J.: Detection and elimination of cellular nucleic acids in biologicals produced on continuous cell lines. Develop Biol Stand 50: 59–69 (S. Karger, Basel), 1982
Google Scholar

References

Aldershvile, J., Roggendorf, M., Kryger, P., Tage-Jensen, U., Deinhardt, F., Frösner, G. G., Hardt, F., Nielsen, J. O. & the Copenhagen Hepatitis Acuta Programme: Liver 1: 290–297, 1981
PubMedGoogle Scholar
Aldershvile, J., Dietrichson, O., Skinhoj, P., Kryger, P., Mathiesen, L. R., Christoffersen, P., Nielsen, J. O. & the Copenhagen Hepatitis Acuta Programme: Chronic persistent hepatitis: Serological classification and meaning of the hepatitis B e system. Liver (in press)
Google Scholar
Bradley, D. W., Maynard, J. E., Hindman, S. H., Hornbeck, C. L., Fields, H. A., McCaustland, K. A., Cook, E. H., Jr: Serodiagnosis of viral hepatitis A: Detection of acute phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J Clin Microbiol 5: 521–530, 1977
PubMed Web of Science ®Google Scholar
Bradley, D. W., Fields, H. A., McCaustland, K. A., Maynard, J. E., Decker, R. H., Whittington, R., Overby, L. R.: Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J Clin Microbiol 9: 120–127, 1979
PubMed Web of Science ®Google Scholar
Coulepis, A. G., Locarnini, S. A., Lehmann, N. I., Gust, I. D.: Detection of hepatitis A virus in the feces of patients with naturally acquired infection. J Infect Dis 141: 151–156, 1980
PubMed Web of Science ®Google Scholar
Deinhardt, F.: Predictive value of markers of hepatitis virus infection. J Infect Dis 141: 299–305, 1980
PubMed Web of Science ®Google Scholar
Duermeyer, W., van der Veen, J.: Specific detection of IgM-antibodies by ELISA, applied in hepatitis A. Lancet 2: 684–685, 1978
PubMed Web of Science ®Google Scholar
Khuroo, S. M.: Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 68: 818–824, 1980
PubMed Web of Science ®Google Scholar
Locarnini, S. A., Ferris, A. A., Lehmann, N. I., Gust, I. D.: The antibody response following hepatitis A infection. Intervirology 8: 309–318, 1977
PubMed Web of Science ®Google Scholar
Locarnini, S. A., Coulepis, A. G., Stratton, A. M., Kaldor, J., Gust, I. D.: Solid phase enzyme-linked immunosorbent assay for detection of hepatitis A specific immunoglobulin M. J Clin Microbiol 9: 459–465, 1979
PubMed Web of Science ®Google Scholar
Roggendorf, M., Frösner, G. G., Deinhardt, F., Scheid, R.: Comparison of solid phase test systems for demonstrating antibodies against hepatitis A virus (anti-HAV) of the IgM class. J Med Virol 5: 47–62, 1980
PubMed Web of Science ®Google Scholar
Roggendorf, M., Deinhardt, F., Frösner, G. G., Scheid, R., Bayerl, B., Zachoval, R.: Immunoglobulin M antibodies to hepatitis B core antigen: Evaluation of enzyme immunoassay for diagnosis of hepatitis B virus infection. J Clin Microbiol 13: 618–626, 1981
PubMed Web of Science ®Google Scholar
Tabor, E., Frösner, G. G., Deinhardt, F., Gerety, R. J.: Hepatitis B e antigen and antibody: Detection by radioimmunoassay in chimpanzees during experimental hepatitis B. J Med Virol 6: 91–99, 1980
PubMed Web of Science ®Google Scholar
von der Helm, K., Winnacker, E. L., Deinhardt, F., Frösner, G. G., Gauss-Müller, V., Bayerl, B., Scheid, R., Siegl, G.: Cloning of hepatitis A virus genome. J Virol Methods 3: 37–43, 1981
PubMed Web of Science ®Google Scholar
Wands, J. R., Marciniak, R. A., Isselbacher, K. J., Varghese, M., Don, G., Halliday, J. W., Powell, L. W.: Demonstration of previously undetected hepatitis B viral determinants in an Australian aboriginal population by monoclonal anti-HBs antibody radioimmunoassays. Lancet 1: 977–980, 1982
PubMed Web of Science ®Google Scholar
Will, H., Cattaneo, R., Koch, H.-G., Darai, G., Schaller, H., Schellekens, H., van Eerd, P. M. C. A., Deinhardt, F.: Cloned HBV DNA causes hepatitis in chimpanzees. Nature (London), 1982 (in press)
Google Scholar
Wong, D. C., Purcell, R. H., Screenivasan, M. A., Prasad, S. R., Parvi, K. M.: Epidemic and endemic hepatitis in India: Evidence for a non-A, non-B hepatitis virus of etiology. Lancet 2: 876–879, 1980
PubMed Web of Science ®Google Scholar

References

Picciotto, A., Crovari, P., Cuneo-Crovari, P., De-Flora, S., Dodero, M. & Celle, G.: Interplay of cell and serum immunologic markers in chronic persistent or active hepatitis B. J Med Virol 8: 195, 1981
PubMed Web of Science ®Google Scholar
Raimondo, G., Smedile, A., Gallo, L., Balbo, A., Ponzetto, A. & Rizzetto, M.: Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet 1: 249, 1982
PubMed Web of Science ®Google Scholar
Rizzetto, M., Canese, M. G., Gerin, J. L., London, W. T., Sly, L. D. & Purcell, R. H.: Transmission of hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 141: 590, 1980
PubMed Web of Science ®Google Scholar
Rizzetto, M., Hoyer, B., Canese, M. G., Shih, J. W. K., Purcell, R. H. & Gerin, J. L.: Delta antigen: The association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta infected chimpanzees. Proc Natl Acad Sci 27: 6124, 1980
Google Scholar
Rizzetto, M.: Biology and characterisation of the delta agent. In: Viral hepatitis, pp. 355–360 (ed. H. Alter, J. Maynard & W. Szmuness). Franklin Institute Press, Philadelphia 1982
Google Scholar
Rizzetto, M., Purcell, R. H. & Gerin, J. L.: Epidemiology of HBV associated delta antigen: Geographical distribution and prevalence in poly-transfused HBsAg carriers. Lancet 1: 1215, 1980
PubMed Web of Science ®Google Scholar
Rizzetto, M., Morello, C., Mannucci, P. M., Gocke, D. J., Spero, J. A., Lewis, J. H., Vanthiel, D. H., Scaroni, C. & Peyretti, F.: Delta-infection and liver disease in hemophilic carriers of hepatitis-B surface antigen. J Infect Dis 145: 18, 1982
PubMed Web of Science ®Google Scholar
Rizzetto, M., Canese, M. G., Aricò, S. : Immunofluorescence detection of a new antigen/antibody system (delta/anti-delta) associated with hepatitis B virus in liver and serum of HBsAg carriers. Gut 18: 997, 1977
PubMed Web of Science ®Google Scholar
Rizzetto, M., Shih, J. W. K., Gocke, D. J., Purcell, R. H., Verme, G. & Gerin, J. L.: Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet 2: 986, 1979
PubMed Web of Science ®Google Scholar
Smedile, A., Lavarini, C., Crivelli, O., Raimondo, G., Fassone, M. & Rizzetto, M.: Radioimmunoassay detection of IgM antibodies to the HBV-associated delta antigen: Clinical significance in delta infection. J Med Virol 9: 131, 1982
PubMed Web of Science ®Google Scholar
Stoecklin, E., Gudat, F., Krey, G. : Delta antigen in hepatitis B: Immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV-infection. Hepatology 1: 238, 1981
PubMed Web of Science ®Google Scholar

References

Alter, M. J., Gerety, R. J., Smallwood, L. A., Sampliner, R. E., Tabor, E., Deinhardt, F., Frösner, G. & Matanoski, G. M.: Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban U.S. population. J Infect Dis 145: 886, 1982
PubMed Web of Science ®Google Scholar
Hoofnagle, J. H., Gerety, R. J., Tabor, E., Feinstone, S., Purcell, R. H. & Barker, L. F.: Transmission of non-A, non-B hepatitis. Ann Intern Med 87: 14, 1977
PubMed Web of Science ®Google Scholar
Jackson, D., Tabor, E. & Gerety, R. J.: Acute non-A, non-B hepatitis: Specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes. Lancet 1: 1249, 1979
PubMed Web of Science ®Google Scholar
Tabor, E., Gerety, R. J., Drucker, J. A., Seeff, L. B., Hoofnagle, J. H., Jackson, D. R., April, M., Pineda-Tamondong, G. & Barker, L. F.: Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1: 463, 1978
PubMed Web of Science ®Google Scholar
Tabor, E., April, M., Seeff, L. B. & Gerety, R. J.: Acute non-A, non-B hepatitis. Prolonged presence of the infectious agent in blood. Gastroenterol 76: 680, 1979
PubMed Web of Science ®Google Scholar
Tabor, E., Hoofnagle, J. H., Smallwood, L. A., Drucker, J. A., Pineda-Tamondong, G. C., Ni, L. Y., Greenwalt, T. J., Barker, L. F. & Gerety, R. J.: Studies of donors who transmit posttransfusion hepatitis. Transfusion 19: 725, 1979
PubMed Web of Science ®Google Scholar
Tabor, E., Seeff, L. B. & Gerety, R. J.: Chronic non-A, non-B hepatitis carrier state. Transmissible agent documented in one patient over a six-year period. N Engl J Med 303: 139, 1980
Web of Science ®Google Scholar
Tabor, E., Peterson, D. A., April, M., Seeff, L. B. & Gerety, R. J.: Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol 5: 103, 1980
PubMed Web of Science ®Google Scholar
Tabor, E., April, M., Seeff, L. B. & Gerety, R. J.: Acquired immunity to human non-A, non-B hepatitis: Cross-challenge of chimpanzees with three infectious human sera. J Infect Dis 140: 789, 1979
PubMed Web of Science ®Google Scholar
Tabor, E. & Gerety, R. J.: The chimpanzee animal model for non-A, non-B hepatitis: New applications. Symposium on Viral Hepatitis, New York, USA, 1980, p. 305.
Google Scholar
Tabor, E. & Gerety, R. J.: Inactivation of an agent of human non-A, non-B hepatitis by formalin. J Infect Dis 142: 767, 1980
PubMed Web of Science ®Google Scholar

References

Blumberg, B. S.: Polymorphisms of the serum proteins and the development of isoprecipitins in transfudes patients. Bull NY Acad Med 40: 377–386, 1964
PubMedGoogle Scholar
Blumberg, B. S., Gerstley, B. J. S., Hungerford, D. A., London, W. T. & Sutnick, A. I.: A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann Intern Med 66: 924, 1967
PubMed Web of Science ®Google Scholar
Francis, D. P., Hadler, S. C., Thompson, S. E., : The prevention of hepatitis B vaccine: Report of the CDC multicenter efficacy trial among homosexual men. Ann Intern Med (in press)
Google Scholar
Hilleman, M. R., Buynak, E. B., Roehm, R. R., Tytell, A. A., Bertland, A. U., Lampson, G. P. : Purified and inactivated human hepatitis B vaccine: Progress report. Am J Med Sci 270: 401–404, 1975
PubMed Web of Science ®Google Scholar
Hilleman, M. R., Bertland, A., Buynale, E., Lampson, G., McAleer, W., McLean, A., Roehm, R. & Tytell, A.: Clinical and laboratory studies of HBsAg vaccine. In: Viral hepatitis, pp. 525–537 (ed. G. N. Vyas ). Franklin Institute Press, Philadelphia 1978
Google Scholar
Hilleman, M., Buynale, E., McAleer, N. & McLean, A.: Human Hepatitis B vaccine. In: Proceedings of the European Symposium on Hepatitis B, pp. 120–139, M.S.D., 1981
Google Scholar
Iwarson, S., Wahl, M. & Hermodsson, S.: Hepatitis B in institutionalized, mentally retarded individuals. In: Proceedings of the European Symposium on Hepatitis B, pp. 83–93, M.S.D., 1981
Google Scholar
Krugman, S., Giles, J. P. & Hammond, J.: Viral hepatitis, type B (MS-2 strain): Studies on active immunization. Am J Med Ass 217: 41–45, 1971
PubMed Web of Science ®Google Scholar
Maupas, P., Godeau, A., Coursaget, P. & Drucker, J.: Immunisation against Hepatitis B in man. Laboratory of Virology, Department of Microbiology, Faculty of MED. Tours, France. Lancet, June 26: 1367–1370, 1976
Google Scholar
Maupas, P., Goudeau, A., Coursaget, P., Drucker, J., Barin, F. & André, M.: Immunization against hepatitis B in man: A pilot study of two yr duration. In: Viral hepatitis pp. 539–556 ed. G. N. Vyas ). Franklin Institute Press, Phialdelphia 1978
Google Scholar
Stevens, C. E., Szmuness, W., Goodman, A. I., Weseley, S. A. & Fotino, M.: Hepatitis B vaccine: Immune responses in haemodialysis patients. Lancet, Dec. 6: 1211–1213, 1980
Google Scholar
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrisson, J. M. & Kellner, A.: Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New Engl J Med 303: 833–841, 1980
PubMed Web of Science ®Google Scholar
Szmuness, W., Stevens, C. E., Zang, E. A., Harley, E. J. & Kellner, A.: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report. Hepatology, vol. I, no. 5, pp. 337–385, 1981
Google Scholar
Szmuness, W., Stevens, C. E., Oleszko, W. R. & Goodman, A.: Passive-active immunisation against hepatitis B: Immunogenicity studies in adult Americans. Lancet, March 14: 576–577, 1981
Google Scholar
Weibel, R. E., Stokes, J.: Alum-Adsorbed Inactivated Hepatitis B Vaccine (Study 594, MSD Files, 1980)
Google Scholar

References

Lee, H. W.: Korean hemorrhagic fever. Prog Med Virol 28: 96–113, 1982
PubMedGoogle Scholar
Lee, H. W., Lee, M. C. & Cho, K. S.: Management of Korean haemorrhagic fever. Med Prog 2: 15–21, 1980
Google Scholar
Smadel, J. E.: Epidemic hemorrhagic fever. Am J Publ Hlth 43: 1327–1330, 1951
Web of Science ®Google Scholar
Smorodintsev, A. A., Altshuller, I. S., Dunaevskii, M. I., Kakhreidze, K. A., Neustroev, V. D. & Churilov, A. V.: Etiology and clinics of hemorrhagic nephroso-nephritis, pp. 26–47. Medgiz Publishers, Moscow 1944
Google Scholar
Ishii, S., Ando, K., Watanabe, N., Murakami, R., Nagayama, T. & Ishikawa, T.: Studies on Songo fever. Jap Army Med J 355: 1755–1758, 1942
Google Scholar
Kitano, M.: A study of epidemic hemorrhagic fever. J Manchou Med 40: 191–209, 1944
Google Scholar
Myhrman, G.: Nephropathia epidemica, a new infectious disease in Northern Scandinavia. Acta Med Scand 140: 52–56, 1951
PubMedGoogle Scholar
Gaon, J., Karlovac, M., Gresikova, M., Hlaca, D., Rukavania, J., Kuezevic, V., Saratlic-Savic, D. & Vampotic, A.: Epidemiological features of hemorrhagic fever. Folia Med Fac Med Univ Saraeviensis 3: 24–41, 1968
Google Scholar
Tamura, M.: Occurrence of epidemic hemorrhagic fever in Osaka City: First cases found in Japan with characteristic feature of marked proteinuria. Biken J 7: 79–94, 1964
PubMedGoogle Scholar
Gajdusek, D. C.: Virus hemorrhagic fever. J Pediatr 60: 851–857, 1962
Web of Science ®Google Scholar
Lee, H. W. & Lee, P. W.: Korean hemorrhagic fever. I. Demonstration of causative antigen and antibodies. Korean J Intern Med 19: 371–384, 1976
Google Scholar
Lee, H. W., Lee, P. W. & Johnson, K. M.: Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 137: 298–308, 1978
PubMed Web of Science ®Google Scholar
French, G. R., Foulke, R. S., Brand, O. A., Eddy, G. A., Lee, H. W. & Lee, P. W.: Propagation of etiologic agent of Korean hemorrhagic fever in a cultured continuous cell line of human origin. Science 211: 1046–1048, 1981
PubMed Web of Science ®Google Scholar
Lee, H. W., Lee, P. W., Lähdevirta, J. & Brummer-Korvenkontio, M.: Aetiological relation between Korean hemorrhagic fever and nephropathia epidemica. Lancet 1: 186–187, 1979
PubMed Web of Science ®Google Scholar
Svedmyr, A., Lee, H. W., Berglund, A., Hoorn, B., Nyström, K. & Gajdusek, D. C.: Epidemic nephropathy in Scandinavia is related to Korean hemorrhagic fever. Lancet 1: 100, 1979
PubMed Web of Science ®Google Scholar
Lee, P. W., Gajdusek, D. C., Gibbs, C. J. & Xu, Z. Y.: Aetiological relation between Korean hemorrhagic fever and epidemic hemorrhagic fever with renal syndrome in People's Republic of China. Lancet 1: 819–820, 1980
PubMed Web of Science ®Google Scholar
Lee, H. W., Lee, P. W., Tamura, M., Tamura, T. & Okuno, Y.: Etiological relation between Korean hemorrhagic fever and epidemic hemorrhagic fever in Japan. Biken J 22: 41–44, 1979
PubMedGoogle Scholar
Svedmyr, A., Lee, H. W., Gajdusek, D. C., Gibbs, C. J. & Nyström, K.: Antigenic differentiation of the viruses causing Korean hemorrhagic fever and epidemic (endemic) nephropathy of Scandinavia. Lancet 2: 315–316, 1980
PubMed Web of Science ®Google Scholar
Lee, H. W. & Antoniadis, A.: Serologic evidence for Korean hemorrhagic fever in Greece. Lancet 1: 832, 1981
PubMed Web of Science ®Google Scholar
Lee, P. W., Gibbs, C. J., Gajdusek, D. C. & Svedmyr, A.: Antibody to Korean hemorrhagic fever virus in man in parts of the World where hemorrhagic fever with renal syndrome is not known. Lancet 1: 256–257, 1981
PubMed Web of Science ®Google Scholar
Lee, H. W., Bark, D. H., Back, L. J., Choi, K. S., Whang, Y. N. & Woo, M. S.: Korean hemorrhagic fever patients in urban areas of Seoul. Korean J Virol 10: 1–6, 1980
Google Scholar
Umenai, T., Lee, H. W., Lee, P. W., Saito, T., Toyoda, T., Hongo, M., Hoshinaga, K., Nobunaga, T., Horiuchi, T. & Ishida, N.: Korean hemorrhagic fever in staff in an animal laboratory. Lancet 1: 1314–1316, 1979
PubMed Web of Science ®Google Scholar
Lee, H. W., Baek, L. J., Kawamata, J., Yamanouchi, T., Miyamoto, H., Hamada, C. & Tamura, T.: Sero-epidemiologic studies of laboratory infections with Hantaan virus, etiologic agent of KHF, in Korea and in Japan. (In preparation, 1982.)
Google Scholar
Lee, H. W., French, G. R., Lee, P. W., Baek, L. J., Tsuchiya, K. & Foulke, R. S.: Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am J Trop Med Hyg 30: 477–482, 1981
PubMed Web of Science ®Google Scholar
White, J. D., Shirey, F. G., French, G. R., Huggins, J. W., Brand, O. M. & Lee, H. W.: Hantaan virus, etiologic agent of Korean hemorrhagic fever, has Bunyaviridae-like morphology. Lancet 1: 768–771, 1982
PubMed Web of Science ®Google Scholar
Brummer-Korvenkontio, M., Vaheri, A., von Bonsdorff, C. H., Vuorimies, J., Manni, T., Penttinen, K., Oker-Blom, N. & Lähdevirta, J.: Nephropathia epidemica: Detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 141: 131–134, 1980
PubMed Web of Science ®Google Scholar
Kasahara, S., Kitano, M., Kikuchi, H., Sakyuama, M., Kanazawa, K., Nezu, N., Yoshimura, M. & Kudo, T.: Studies on pathogen of epidemic hemorrhagic fever. J Jap Pathol 34: 3–5, 1944
Google Scholar
Lee, H. W., Lee, P. W., Baek, L. J., Song, C. K. & Seong, I. W.: Intraspecific transmission of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am J Trop Med Hyg 30: 1106–1112, 1981
PubMed Web of Science ®Google Scholar
Lee, H. W., Baek, L. J. & Johnson, K. M.: Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis (November 1982)
Google Scholar

References

Lee, H.W., Lee, P.-W. & Johnson, K. M.: Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis 137: 298, 1978
PubMed Web of Science ®Google Scholar
Svedmyr, A., Lee, H. W., Berglund, A., Hoorn, B., Nyström, K. & Gajdusek, D. C.: Epidemic nephropathy in Scandinavia is related to Korean haemorrhagic fever. Lancet 1: 100, 1979
PubMed Web of Science ®Google Scholar
Lee, H. W., Lee, P.-W., Lähdevirta, J. & Brummer-Korvenkontio, M.: Aetiological relation between Korean haemorrhagic fever and nephropathia epidemica. Lancet 1: 186, 1979
PubMed Web of Science ®Google Scholar
Svedmyr, A., Lee, P.-W., Gajdusek, D. C., Gibbs, C. J., Jr & Nyström, K.: Antigenic differentiation of the viruses causing Korean haemorrhagic fever and epidemic (endemic) nephropathy of Scandinavia. Lancet 2: 315, 1980
PubMed Web of Science ®Google Scholar
Lee, P.-W., Svedmyr, A., Gajdusek, D. C., Gibbs, C. J., Jr & Nyström, K.: Antigenic difference between European and East Asian viruses causing haemorrhagic fever with renal syndrome. Lancet 2: 256, 1981
PubMed Web of Science ®Google Scholar
Lee, P.-W., Amyx, H. L., Gibbs, C. J., Jr & Gajdusek, D. C.: The susceptibility of nude mice to Korean hemorrhagic fever virus. (In preparation.)
Google Scholar
French, G. R., Foulke, R. S., Brand, O. A., Eddy, G. A., Lee, H. W. & Lee, P.-W.: Korean hemorrhagic fever: Propagation of the etiologic agent in a cell line of human origin. Science 211: 1046, 1980
Web of Science ®Google Scholar
Brummer-Korvenkontio, M., Vaheri, A., Hovi, T., von Bonsdorff, C. H., Vuorimies, J., Manni, T., Penttinen, K., Oker-Blom, N. & Lähdevirta, J.: Nephropathia epidemica: Detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 141: 131, 1980
PubMed Web of Science ®Google Scholar
Lee, P.-W., Goldgaber, D., Svedmyr, A., Gajdusek, D. C., Gibbs, C. J., Jr & Amyx, H. L.: Differentiation of nephropathia epidemica from East Asian strains of hemorrhagic fever with renal syndrome by blocking antibody and neutralizing antibody determinations. N Engl J Med (in press)
Google Scholar
Tkachenko, E. A., Donets, M. A., Rezapkin, G. V., Dzagurova, T. K., Ivanov, A. P., Leschchinskaya, E. V., Reshetnikov, I., Drozdov, S. G., Slonova, R. A. & Somov, G. P.: Serotypes of HFRS (Hemorrhagic fever with renal syndrome) virus in East European and Far Eastern USSR. Lancet 1: 863, 1982
PubMed Web of Science ®Google Scholar

References

Brummer-Korvenkontio, M., Vaheri, A., Hovi, T., von Bonsdorff, C.-H., Vuorimies, J., Manni, T., Penttinen, K., Oker-Blom, N. & Lähdevirta, J.: Nephropathia epidemica. Detection of antigen in bank voles and serologic diagnosis of human infection. J Inf Dis 141: 131–134, 1980
PubMed Web of Science ®Google Scholar
Chumakov, M. P. & Gavrilovskaya, I. N.: Are there two serotypes of the agent of hemorrhagic fever with renal syndrome? Lancet, Sept. 27: 691, 1980
Google Scholar
Lähdevirta, J.: Nephropathia epidemica in Finland. A clinical, histological and epidemiological study. Ann Clin Res 3 ( Suppl. 8): 1–154, 1971
PubMedGoogle Scholar
Lee, H. W., Lee P. W. & Johnson, K. M.: Isolation of the etiological agent of Korean hemorrhagic fever. J Inf Dis 137: 298–308, 1978
PubMed Web of Science ®Google Scholar
Lee, H. W., Lee, P. W., Lähdevirta J. & Brummer-Korvenkontio, M.: Aetiological relation between Korean haemorrhagic fever and nephropathia epidemica. Lancet i: 186–187, 1979
Google Scholar
Lee, H. W., Lee, P. W., Baek, L. J., Song, C. K. & Seong, I. W.: Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am J Trop Med Hyg 30: 1106–1112, 1981
PubMed Web of Science ®Google Scholar
Oker-Blom, N., von Bonsdorff, C.-H., Brummer-Korvenkontio, M., Hovi, T., Penttinen, K., Saikku, P., Vaheri, A. & Lähdevirta, J.: Nephropathia epidemica in Finland. In: Arctic and tropical arboviruses ed. E. Kurstak), pp. 197–209. Academic Press, 1979
Google Scholar
Svedmyr, A., Lee, P. W., Gajdusek, D. C., Gibbs, C. J. & Nyström K.: Antigenic differentiation of the viruses causing Korean hemorrhagic fever and epidemic (endemic) nephropathy of Scandinavia. Lancet ii: 315–316, 1980
Google Scholar

References

Nyström, K.: Incidence and prevalence of endemic benign (epidemic) nephropathy in AC county, Sweden, in relation to population density and prevalence of small rodents. Acta Med Scand 1977, Suppl. 609
Google Scholar
Hörnfeldt, B.: Small rodent project [Basinventering av gnagare (BIG)]. Department of Ecological Zoology, Umeå University. Mimeographed reports 1975–1981
Google Scholar
Myers, J. H. & Krebs, C. J.: Population cycles in rodents. Sci Am 230: 38–46, 1974
PubMed Web of Science ®Google Scholar
Lee, H.-W.: Korean hemorrhagic fever. Prog Med Virol 28: 96–113, 1982
PubMedGoogle Scholar

References

Gajdusek, D. C.: Acute infectious hemorrhagic fevers and mycotoxicoses in the Union of Soviet Socialist Republics. Walter Reed Army Medical Center. Washington 1953
Google Scholar
Hortling, H.: En epidemi av fältfeber (?) i finska Lappland. Nord Med 30: 1001, 1946
Google Scholar
Lee, J. S., Cho, B. Y., Lee, M. C., Choi, S. J., Kim, K. W. & Lee, M.: Clinical features of serologically proven Korean Hemorrhagic fever patients. Seoul J Med 21: 163, 1980
Google Scholar
Lee, M.: Korean hemorrhagic fever. Seoul National University Press, Seoul, 1981
Google Scholar
Myhrman, G.: En njursjukdom med egenartad symptombild. Nord Med Tidsskr 7: 793, 1934
Google Scholar
Myhrman, G.: En ny infektionssjukdom i Nordsverige och Nordfinland. Nord Med 28: 2571, 1945
Google Scholar
Lähdevirta, J.: Nephropathia epidemica in Finland. A clinical, histological and epidemiological study. Ann Clin Res 3: Suppl. 8, 1971
PubMedGoogle Scholar
Lähdevirta, J. & Elo, O.: Nephropathia epidemican esiintyminen Suomessa vuosina 1966–1973. Suom Lääk lehti 30: 677, 1975
Google Scholar
Lähdevirta, J.: Unpublished data.
Google Scholar
Stuhlfauth, K.: Bericht über ein neues schlammfieberähnliches Krankheitsbild bei deutschen Truppen in Lappland. Dtsch Med Wochenschr 69: 439, 474, 1943
Google Scholar
Zetterholm, S. G.: Akuta nefriter simulerande akuta bukfall. Läkartidningen 31: 425, 1934
Google Scholar

References

Brummer-Korvenkontio, M., Vaheri, A., Hovi, T., von Bonsdorff, C.-H., Vuorimies, J., Manni, T., Penttinen, K., Oker-Blom, N. & Lähdevirta, J.: Nephropathia epidemica: Detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 141: 131–134, 1980
PubMed Web of Science ®Google Scholar
Chumakov, M. P.: Etiology, epidemiology and prophylaxis of hemorrhagic fevers. Public Health Monography No. 50 (Supplement No. 1), U.S. Public Health Service, U.S. Government Printing Office, Washington D.C., pp. 19–25, 1957
Google Scholar
Cohen, M. D., Casals, J., Hsiung, G. D., Kwei, H.-E., Chin, C.-C., Ge, H.-C., Hsiang, C.-M., Lee, P.-W., Gibbs, C. J., Jr & Gajdusek, D. C.: Epidemic hemorrhagic fever in Hubei province, the People's Republic of China: A clinical and serological study. Yale J Biol Med 54: 41–55, 1981
PubMed Web of Science ®Google Scholar
French, G. R., Foulke, R.-S., Brand, O. A., Eddy, G. A., Lee, H. W. & Lee, P. W.: Korean hemorrhagic fever: Propagation of the etiologic agent in a cell line of human origin. Science 211: 1046–1048, 1981
PubMed Web of Science ®Google Scholar
Gajdusek, D. C.: Acute infectious hemorrhagic fevers and mycotoxicoses in the Union of Soviet Socialist Republics, Medical Science Publication 2, Walter Reed Army Medical Center, Washington D.C., 1953, 140 pp.
Google Scholar
Gajdusek, D. C.: Hemorrhagic fevers in Asia: A problem in medical ecology. Geographic Review 46: 20–42, 1956
Web of Science ®Google Scholar
Gajdusek, D. C.: Das epidemische hämorrhagische Fieber. Klin Wochenschr 34: 769–777, 1956
PubMedGoogle Scholar
Gajdusek, D. C.: Virus hemorrhagic fevers, special reference to hemorrhagic fever with renal syndrome (epidemic hemorrhagic fever). J Pediatr 60: 141–157, 1962
Web of Science ®Google Scholar
Gajdusek, D. C., Goldgaber, D., Millard, E. & Ono, S. G.: Bibliography of hemorrhagic fever with renal syndrome (muroid virus nephropathy). National Institutes of Health, Bethesda, Maryland 1982, 155 pp.
Google Scholar
Lähdevirta, J.: Nephropathia epidemica in Finland. Ann Clin Res 3: 1–154, 1971
PubMedGoogle Scholar
Lee, H. W. & Lee, P. W.: Korean hemorrhagic fever. I. Demonstration of causative antigen and antibodies. Korean J Intern Med (Seoul) 19: 371–383, 1976
Google Scholar
Lee, H. W. & Lee, P. W.: Korean hemorrhagic fever. II. Isolation of etiologic agent. Korean J Virol (Seoul) 7: 19, 1977
Google Scholar
Lee, H. W., Lee, P. W. & Johnson, K. M.: Isolation of the etiological agent of Korean hemorrhagic fever. J Infect Dis 137: 298–308, 1978
PubMed Web of Science ®Google Scholar
Lee, P. W., Gajdusek, D. C., Gibbs, C. J., Jr & Xu, Z.-Y.: Aetiological relation between Korean haemorrhagic fever and haemorrhagic fever with renal syndrome in People's Republic of China. Lancet 1: 819–820, 1980
PubMed Web of Science ®Google Scholar
Lee, P. W., Gibbs, C. J., Jr, Gajdusek, D. C., Hsiang, C. M. & Hsiung, G. D.: Identification of epidemic haemorrhagic fever with renal syndrome in China with Korean haemorrhagic fever. Lancet 1: 1025–1026, 1980
PubMed Web of Science ®Google Scholar
Lee, P. W., Yanagihara, R., Franko, M. C., Amyx, H. L., Gibbs, C. J. Jr, Gajdusek, D. C. & Traub, R.: Preliminary evidence that Hantaan or a closely related virus is enzootic in domestic rodents. N Engl J Med 307: 624–625, 1982
Google Scholar
Smorodintsev, A. A., Chudakov, B. G. & Churilov, A. V.: Haemorrhagic nephroso-nephritis. Translated from the Russian by Catherine Matthews. Pergamon Press, London and New York 1959, 124 pp.
Google Scholar
Smorodintsev, A. A., Kazbintsev, L. I. & Chudakov, V. G.: Virus hemorrhagic fevers. Published by the National Library of Medicine on behalf of the National Science Foundation, Washington, D.C. 1964, 245 pp.
Google Scholar
Svedmyr, A., Lee, H. W., Berglund, A., Hoorn, B., Nyström, K. & Gajdusek, D. C.: Epidemic nephropathy in Scandinavia is related to Korean haemorrhagic fever. Lancet 1: 100, 1979
PubMed Web of Science ®Google Scholar
Trencséni, T. & Keleti, B.: Clinical aspects and epidemiology of haemorrhagic fever with renal syndrome: Analysis of clinical and epidemiological experiences in Hungary. Akademiai Kiado, Budapest, 248 pp.
Google Scholar

References

Appleman, M. D., Swinney, R. S. & Heseltine, P. N. R.: Evaluation of the antimicrobial removal device. J Clin Microbiol 15: 278–281, 1982
PubMed Web of Science ®Google Scholar
Auckenthaler, R. D., Ilstrup, D. M. & Washington, J. A. II: Comparison of recovery of organisms from blood cultures diluted 10% (volume/volume) and 20% (volume/volume). J Clin Microbiol 15: 860–864, 1982
PubMed Web of Science ®Google Scholar
Mirrett, S., Lauer, B. A., Miller, G. A. & Reller, L. B.: Comparison of acridine orange, methylene blue, and Gram stains for blood cultures. J Clin Microbiol 15: 562–566, 1982
PubMed Web of Science ®Google Scholar
Pazin, G. J., Saul, S. & Thompson, M. E.: Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 142: 263–268, 1982
PubMedGoogle Scholar
Salventi, J. F., Davis, F. A., Randall, E. L., Whitaker, A. & Waters, J. R.: Effect of blood dilution on recovery of organisms from clinical blood cultures in medium containing sodium polyanethosulfonate. J Clin Microbiol 9: 248–252, 1979
PubMed Web of Science ®Google Scholar
Sandven, P. & Høiby, E. A.: The importance of blood volume cultured on detection of bacteraemia. Acta Pathol Microbiol Scand Sect. B 89: 149–152, 1981
Google Scholar
Tenney, J. H., Reller, L. B., Mirrett, S., Wang, W.-L. L. & Weinstein, M. P.: Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol 15: 558–562, 1982
PubMed Web of Science ®Google Scholar
Wallis, C., Melnick, J. L., Wende, R. D. & Riely, P. E.: Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal devide. J Clin Microbiol 11: 462–464, 1980
PubMed Web of Science ®Google Scholar
Washington, J. A. II: Conventional approaches to blood culture. In: The detection of septicemia ed. J. A. Washington II), pp. 41–88. CRC Press, West Palm Beach, Fla. 1978
Google Scholar
Werner, A. S., Cobbs, C. G., Kaye, D. & Hook, E. W.: Studies on the bacteremia of bacterial endocarditis. JAMA 202: 199–203, 1967
PubMed Web of Science ®Google Scholar
Wright, A. J., Thompson, R. L., McLimans, C. A., Wilson, W. R. & Washington, J. A. II: The antimicrobial Removal Device: a microbiological and clinical evaluation. Am J Clin Pathol 78, 1982
Google Scholar

References

Peltola, H.: C-reactive protein for rapid monitoring of infections of the central nervous system. Lancet i: 980–982, 1982
Google Scholar
Komorowski, R. A., Farmer, S. G., Hanson, G. A. & Hause, L. L.: Cerebrospinal fluid lactic acid in diagnosis of meningitis. J Clin Microbiol 8: 89–92, 1978
PubMed Web of Science ®Google Scholar
Baker, C. J., Webb, B. J., Jackson, C. V. & Edwards, M. S.: Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease. Pediatrics 65: 1110–1114, 1980
PubMed Web of Science ®Google Scholar
Ingram, D. L., Pendergrass, E. L., Bromberger, P. I., Thullen, J. D., Yoder, C. D. & Collier, A. M.: Group B streptococcal disease. Its diagnosis with the use of antigen detection, Gram's stain and the presence of apnea, hypotension. Am J Dis Child 134: 754–758, 1980
PubMedGoogle Scholar
Rytel, M. W.: Counterimmunoelectrophoresis in diagnosis of infectious disease. Hospital Practise 10: 75–82, 1975
Google Scholar
Kaldor, J., Asznowicz, R. & Buist, D. P. Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia. Am J Clin Pathol 68: 284–289, 1977
PubMed Web of Science ®Google Scholar
Doskeland, S. O. & Berdal, B. P.: Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions. J Clin Microbiol 11: 380–384, 1980
PubMed Web of Science ®Google Scholar
Severin, W. P. J.: Latex agglutination in the diagnosis of meningococcal meningitis. J Clin Pathol 25: 1079–1082, 1972
PubMed Web of Science ®Google Scholar
Olcén, P., Danielsen, D. & Kjellander, J.: The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta Pathol Microbiol Scand B83: 387–396, 1975
Google Scholar
Yolken, R. H.: Enzyme immunoaassay for the detection of infectious antigens in body fluids: current limitations and future prospects. Rev Infect Dis 4: 35–68, 1982
PubMedGoogle Scholar
Leinonen, M. & Käyhty, H.: Comparison of counter-current immunoelectrophoresis, latex agglutination, and radioimmunoassay in detection of soluble capsular polysaccharide antigens of Haemophilus influenzae type b and Neisseria meningitidis of groups A or C. J Clin Pathol 31: 1171–1176, 1978
Web of Science ®Google Scholar
Whittle, H. C. : The bacteriological diagnosis of pyogenic meningitis from cerebrospinal fluid dried on filter paper. Transactions of the Royal Society of Tropical Medicine and Hygiene 70: 217–218, 1976
PubMed Web of Science ®Google Scholar
Käyhty, H., Jousimies-Somer, H., Peltola, H. & Mäkelä, P. H.: Antibody response to capsular polysaccharides of groups A and C Neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis 143: 32–41, 1981
PubMed Web of Science ®Google Scholar
Shenep, J. L., Munson, R. S., Jr & Granoff, D. M.: Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b. J Infect Dis 145: 181–190, 1982
PubMed Web of Science ®Google Scholar
Poolman, J. T. & Zanen, H. C.: Detection of antibody activity in human sera against meningococcal cell wall antigens using a gel-immuno-radio-assay (GIRA). FEMS Microbiol Lett 7: 293–296, 1980
Web of Science ®Google Scholar
Kleemola, M. & Käyhty, H.: Rise to antibodies to Mycoplasma pneumoniae in purulent meningitis. J Infect Dis (in press), 1982
Google Scholar
Austrian, R. & Gold, I.: Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 60: 759–776, 1964
PubMed Web of Science ®Google Scholar
Schreiner, A. & Digranes, A.: Bacteriology of acute lower respiratory tract infections. J Infect, Suppl. 2: 1: 23–30, 1979
Google Scholar
Holliday, M. G.: The diagnosis of Legionnaires' disease by counterimmunoelectrophoresis. J Clin Pathol 33: 1174–1178, 1980
PubMed Web of Science ®Google Scholar
Kaijser, B., Berntsson, E. & Trollfors, B.: Serological diagnosis of pneumococcal pneumonia. J Infect, Suppl. 2: 39–44, 1979
Google Scholar
Yolken, R. H., Hughes, W. T. & Stopa, P. J.: Rapid diagnosis of infections caused by β-lactamase-producing bacteria by means of an enzyme radioisotopic assay. J Pediatr 97: 715–720, 1980
PubMed Web of Science ®Google Scholar

References

Coons, A. H., Creech, H. J., Jones, R. N. & Berliner, E.: The demonstration of pneumococcal antigens in tissues by the use of flourescent antibody. J Immunol 45: 159, 1942
Google Scholar
World Health Organisation: Rapid laboratory techniques for the diagnosis of viral infections. Tech Rep Ser 661: 1–60, 1981
PubMedGoogle Scholar
Gardner, P. S. & McQuillin, J.: Rapid virus diagnosis: application of immunofluorescence, 2nd ed. Butterworths, London 1980
Google Scholar
Respiratory syncytial virus infection in industrial, urban and rural areas as a cause of admission to hospital: A report to the MRC Subcommittee on RSV vaccines. Br Med J 2: 796–798, 1972
Google Scholar
Orstavik : Rapid immunofluorescence diagnosis of respiratory syncytial virus infections among children in European countries. Lancet ii: 32, 1980
Google Scholar
Mossai, R. B., Gardner, P. S., Almeida, J. D. & Greenway, M. A.: A simple immunofluorescent technique for the detection of human rotavirus
Google Scholar
Gardner, P. S. & Kaye, S.: Egg globulins in rapid virus diagnosis. J Virol Meth 257–262, 1982
Google Scholar
Gardner, P. S.: Monoclonal antibodies in relation to viruses and their possible clinical application. Proceedings of the Royal Society of Edinburgh, 81B: 277–291, 1982
Google Scholar
Downham, M. A. P. S., Elderkin, F. M., Platt, J. W. McQuillin, J. & Gardner, P. S.: Rapid virus diagnosis in paediatric units by a postal service: Respiratory syncytial infection in Cumberland. Arch Dis Child 49: 467, 1974
PubMed Web of Science ®Google Scholar

References

Almeida, June D.: Practical aspects of diagnostic electron microscopy. Yale J Biol Med 53: 5–18, 1980
PubMed Web of Science ®Google Scholar
Cohen, B. J. & Richmond, J. E.: Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature 296: 677–678, 1982
PubMed Web of Science ®Google Scholar
Coon, A. H., Creech, H. J., Jones, R. N. & Berliner, E.: The demonstration of pneumococcal antigen in tissues by the use of fluorescent antibody. J Immunol 45: 159, 1942
Google Scholar
Gardner, P. S. & McQuillin, J.: Rapid virus diagnosis: Application of immunofluorescence, 2nd ed. Butterworths, London 1980
Google Scholar
Hsiung, G. D.: Progress in clinical virology 1960 to 1980: A recollection of twenty years. Yale J Biol Med 53: 1–4, 1980
PubMed Web of Science ®Google Scholar
Peters, D., Nielsen, G. & Bayer, M. E.: Variola: die Zuverlässigkeit der elektronenmikroskipischen Schnelldiagnostik. Dt Med Wochenschr 87: 2240–2246, 1962
PubMed Web of Science ®Google Scholar
Serjeant, G. R., Mason, K., Topley, J. M., Serjeant, B. E., Pattison, J. R., Jones, S. E. & Mohamed, R.: Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet II: 595–597, 1981
Google Scholar
Walsh, J. H., Yalow, R. & Berson, S. A.: Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis 121: 550–554, 1970
PubMed Web of Science ®Google Scholar
Wolters, G., Kuijpers, L., Kacaki, J., : Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen. J Clin Pathol 29: 873–879, 1976
PubMed Web of Science ®Google Scholar

References

Aisner, J., Schimpff, S. C. & Wiernik, P. H.: Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 86: 539–545, 1977
PubMed Web of Science ®Google Scholar
Aisner, J., Murillo, J., Schimpff, S. C. & Steere, A. C.: Invasive aspergillosis in acute leukemia. Correlation with nose cultures and antibiotic use. Ann Intern Med 90: 4–8, 1979
PubMed Web of Science ®Google Scholar
Zavala, D. C.: Diagnostic fiberoptic bronchoscopy techniques and results of biopsy in 600 patients. Chest 68: 12–19, 1975
PubMed Web of Science ®Google Scholar
Chandler, F. W., Kaplan, W. & Ajello, L.: Histopathology of mycotic diseases. Wolfe Medical Publ. Ltd., 1980
Google Scholar
Kaplan, W.: Practical application of fluorescent antibody procedures in medical mycology. 3rd Int. Conf. Mycoses. Pan Am. Health Org. Sci. Publ. No. 304, pp. 128–185, 1975
Google Scholar
Katzenstein, A.-L. & Maksen, J.: Candidal infection of gastric ulcers. Am J Pathol 71: 137–141, 1979
Web of Science ®Google Scholar
Meunier-Carpentier, F., Kiehn, T. & Armstrong, D.: Fungemia in the immunocompromized host. Am J Med 71: 363–369, 1981
PubMed Web of Science ®Google Scholar
Odds, F. C.: Candida and candidosis. Baltimore University Park Press, 1979
Google Scholar
Edwards, J. E., Lehrer, R. I., Stiehm, E. R., Fischer, T. J. & Young, L. S.: Severe candidal infections: clinical perspective, immune defense mechanisms and current concepts of therapy. Ann Intern Med 89: 91–106, 1978
PubMed Web of Science ®Google Scholar
Tenny, J. H., Reller, L. B., Mirrett, S., Wang, W.-L. & Weinstein, M. P.: Controlled evaluation of the volume of blood cultured in detection of bacteriemia and fungemia. J Clin Microbiol 15: 558–561, 1982
PubMed Web of Science ®Google Scholar
Washington II, J.: The role of the microbiology laboratory in the diagnosis and antimicrobial treatment of infective endocarditis. Mayo Clin Proc 57: 22–23, 1982
PubMed Web of Science ®Google Scholar
Komarowski, R. A. & Farmer, S. G.: Rapid detection of candidemia. Am J Clin Pathol 59: 56–61, 1973
PubMed Web of Science ®Google Scholar
Miller, G. G., Witer, M. W., Baude, A. I. & Davis, C. E.: Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest 54: 1235–1240, 1974
PubMed Web of Science ®Google Scholar
Tsuchiya, T. Y., Fukazawa, Y., Tagnichi, M., Nakase, T. & Shinoda, T.: Serologic aspects of yeast classification. Mycopathol Mycol Appl 53: 77–92, 1974
PubMedGoogle Scholar
Shinoda, T., Kaufmann, L. & Padhye, A. A.: Serological Candida Check Kit and the API20C Kit for identification of medically important Candida species. J Clin Microbiol 13: 513–518, 1981
PubMed Web of Science ®Google Scholar
Gangopadkyay, P. K., Thadepalli, H., Roy, I. & Ansari, A.: Identification of species of Candida, Cryptococcus and Torulopsis by gasliquid chromatography. J Infect Dis 140: 952–957, 1979
PubMed Web of Science ®Google Scholar
Filic, G., Yu, B. & Armstrong, D.: Immunodiffusion and agglutination tests for Candida in patients with neoplastic diseases: inconsistent correlation of results with invasive infections. J Infect Dis 135: 349–358, 1977
PubMed Web of Science ®Google Scholar
Jeffrey, M. J.: Kinetics of antibody response to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. J Lab Clin Med 96: 845–860, 1980
PubMed Web of Science ®Google Scholar
Holmberg, K., Berdischewsky, M. & Young, L. S.: Serodiagnosis of aspergillosis. J Infect Dis 141: 656–664, 1980
PubMed Web of Science ®Google Scholar
Segal, E., Berg, R. A., Pizzo, P. A. & Bennett, J. E.: Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol 10: 116–118, 1979
PubMed Web of Science ®Google Scholar
Meurnier-Carpentier, F. & Armstrong, D.: Candida antigenemia as detected by passive hemagglutination inhibition assay in patients with disseminated candidiasis or Candida colonization. J Clin Microbiol 13: 10–14, 1981
PubMed Web of Science ®Google Scholar
Bernard, E. W., Christiansen, K. J., Tsang, S.-F., Kiehm, T. E. & Armstrong, D.: Rate of arabinitol production of pathogenic yeast species. J Clin Microbiol 14: 189–194, 1981
PubMed Web of Science ®Google Scholar
Eng, R. H. K., Chmel, H. & Buse, M.: Serum level of arabinitol in the detection of invasive candidiasis in animals and humans. J Infect Dis 143: 677–683, 1981
PubMed Web of Science ®Google Scholar

References

Shapiro, M., Townsend, T. R., Rosner, B. & Kass, E. H.: Use of antimicrobial drugs in general hospitals. N Engl J Med 301: 351–355, 1979
PubMed Web of Science ®Google Scholar
Hoeprich, P. D.: Chemoprophylaxis of infectious diseases. In: Infectious diseases, 2nd (ed. P. D. Hoeprich), pp. 190–206. Harper and Rowe, Hagestown, Maryland 1977
Google Scholar
Finch, W. T., Sawyers, J. L. & Schenker, S.: A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg 183: 667–671, 1976
PubMed Web of Science ®Google Scholar
Britt, M. R., Garibaldi, R. A., Miller, W. A., Hebertson, R. M. & Burke, J. P.: Antimicrobial prophylaxis for catheter-associated bacteriuria. Antimicrob Agents Chemother 11: 240–243, 1977
PubMed Web of Science ®Google Scholar
Brumfitt, W. & Hamilton-Miller, J. M. T.: The place of antibiotic prophylaxis in medicine. J Antimicrob Chemother 1: 163–169, 1975
PubMedGoogle Scholar
Dale, D. C., Alling, D. W. & Wolff, S. M.: Cloxacillin chemoprophylaxis in the Chediak-Higashi syndrome. J Infect Dis 125: 393–397, 1972
PubMed Web of Science ®Google Scholar
Parrillo, J. E., Borst, G. C., Mazur, M., Iannini, P., Klempner, M. S., Moellering, R. C., Jr & Anderson, S. E.: Resistant Streptococcus viridans endocarditis occurring in patients receiving oral penicillin chemothoprophylaxis. N Engl J Med 300: 296–300, 1979
PubMed Web of Science ®Google Scholar
Anonymous: Preventing spread of meningococcal disease. The Medical Letter 23: 37–38, 1981
Google Scholar
Jacobson, J. A. & Fraser, D. W.: A simplified approach to meningococcal disease prophylaxis. J Amer Med Assoc 236: 1053–1054, 1976
PubMed Web of Science ®Google Scholar
Sivonen, A., Renkonen, O.-V., Weckström, P., Koskenvuo, K., Raunio, V. & Mäkalä, P. H.: The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. J Infect Dis 137: 238–244, 1978
PubMed Web of Science ®Google Scholar
Nicolle, L. E., Postl, B., Kotelewetz, E., Remillard, F., Bourgault, A.-M., Albritton, W., Harding, G. K. M. & Ronald, A. R.: Chemoprophylaxis for Neisseria meningiditis in an isolated arctic community. J Infect Dis 145: 103–109, 1982
PubMed Web of Science ®Google Scholar
Granoff, D. M. & Daum, R. S.: Spread of Hemophilus influenzae type b: Recent epidemiologic and therapeutic consideration. J Pediatr 97: 854–860, 1980
PubMed Web of Science ®Google Scholar
Ward, J. L., Fraser, D. W., Baraff, L. J. & Pilikaytis, D. B.: Hemophilus influenzae meningitis. N Engl J Med 301: 122–126, 1979
PubMed Web of Science ®Google Scholar
Cox, F. R., Trincher, R., Rissing, J. P., Patton, N., McCracken, G. H. & Granoff, D. M.: Rifampin prophylaxis for contacts of Hemophilus influenzae type b disease. J Am Med Assoc 245: 1043–1045, 1981
Web of Science ®Google Scholar
Nicolle, L. E., Postl, B., Kotelewetz, E., Albritton, W., Harding, G. K. M., Bourgault, A.-M. & Ronald, A. R.: Emergence of rifampin-resistant Hemophilus influenzae. Antimicrob Agents Chemother 21: 498–500, 1982
PubMed Web of Science ®Google Scholar
Bailey, R. R., Gower, P. E., Roberts, A. P., : Prevention of urinary-tract infection with low-dose nitrofurantoin. Lancet ii: 1112–1114, 1971
Google Scholar
Harding, G. K. M. & Ronald, A. R.: A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med 291: 597–601, 1974
PubMed Web of Science ®Google Scholar
Perrin, J. M., Charney, E., MacWhinney, J. V., Jr, McInerney, T. K., Miller, R. L. & Nazarian, L. F.: Sulfisoxazole as chemoprophylaxis for recurrent otitis media. N Engl J Med 291: 664–667, 1974
PubMed Web of Science ®Google Scholar
Sack, D. A., Kaminsky, D. C., Sack, R. B., : Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of peace corps volunteers in Kenya. N Engl J Med 298: 758–763, 1978
PubMed Web of Science ®Google Scholar
Sack, R. B., Froehlich, J. L., Zulich, A. W., Sidi Hidi, D., Kapikian, A. Z., Orskøv, F., Orskøv, J. & Greenberg, H. B.: Prophylactic doxycycline for travelers' diarrhea. Gastroenterology 76: 1368–1373, 1979
PubMed Web of Science ®Google Scholar
Echeverria, P., Verhaert, L., Ulyangco, V., : Antimicrobial resistance and enterotoxin production among isolates of Escherichia coli in the Far East. Lancet ii: 589–592, 1978
Google Scholar
Murray, B. E., Rensimer, E. & DuPont, H. L.: Emergence of high level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med 306: 130–135, 1982
PubMed Web of Science ®Google Scholar
DuPont, H. L., Sullivan, P., Evans, D. G., : Prevention of travelers' diarrhea (emporiatric enteritis): Prophylactic administration of subsalicylate bismuth. J Am Med Assoc 243: 237–241, 1980
PubMed Web of Science ®Google Scholar
Ericsson, C. D., Feldman, S., Pickering, L. K. & Cleary, T. G.: Influence of subsalicylate bismuth on absorption of doxycycline. J Am Med Assoc 247: 2266–2267, 1982
PubMed Web of Science ®Google Scholar
Jacoby, I. Mandell, L. A. & Weinstein, L.: The chemoprophylaxis of infection. Med Clin N Am 62: 1083–1098, 1978
PubMed Web of Science ®Google Scholar
Anonymous: Immunizations and chemoprophylaxis for travelers. The Medical Letter 23: 105–108, 1981
Google Scholar
Hughes, W. T., Kuhn, S., Chaudhary, S., : Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297: 1419–1426, 1977
PubMed Web of Science ®Google Scholar
Sabin, A. B.: Amantadine and influenza: Evalution of conflicting reports. J Infect Dis 138: 557–566, 1978
PubMed Web of Science ®Google Scholar
Hirschmann, J. V. & Inui, T. S.: Antimicrobial prophylaxis: A critique of recent trials. Rev Infect Dis 2: 1–23, 1980
PubMedGoogle Scholar
American Heart Association Committee on Prevention of Rheumatic Fever: Prevention of Bacterial Endocarditis. Circulation 56: 139A–143A, 1977
PubMed Web of Science ®Google Scholar
Petersdorf, R. G.: Antimicrobial prophylaxis of bacterial endocarditis: Prudent caution or bacterial overkill? Am J Med 65: 220–223, 1978
PubMed Web of Science ®Google Scholar
Brooks, S. L.: Survey of compliance with American Heart Association guidelines for prevention of bacterial endocarditis. J Am Dent Assoc 101: 41–43, 1980
PubMed Web of Science ®Google Scholar
Bender, J. F., Schimpff, S. C., Young, V. M., Fortner, C. L., Brouillet, M. D., Love, L. J. & Wiernik, P. H.: Role of vancomycin as a component of oral non-absorbable antibiotics for microbial suppression in leukemic patients. Antimicrob Agents Chemother 15: 455–460, 1979
PubMed Web of Science ®Google Scholar
Wade, J. C., Schimpff, S. C., Hargadon, M. T., Fortner, C. L., Young, V. M. & Wiernik, P. H.: A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304: 1052–1062, 1981
Web of Science ®Google Scholar
Gurwith, M. J., Brunton, J. L., Lank, B. A., Harding, G. K. M. & Ronald, A. R.: A prospective controlled investigation of prophylactic trimethoprim-sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66: 248–256, 1979
PubMed Web of Science ®Google Scholar
Weiser, B., Lange, M., Fialk, M. A., Singer, C., Szatrowski, T. H. & Armstrong, D.: Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: A controlled trial. Ann Intern Med 95: 436–438, 1981
PubMed Web of Science ®Google Scholar
Moellering, R. C., Jr: The use and abuse of antibiotic combinations. R I Med J 55: 341–360, 1972
PubMedGoogle Scholar

References

Hirschmann, J. V. & Inui, T. S.: Antimicrobial prophylaxis: a critique of recent trials. Rev Infect Dis 2: 1, 1980
PubMedGoogle Scholar
Goodman, J. S., Schaffner, W., Collins, H. A., Battersby, E. J. & Koenig, M. G.: Infection after cardiovascular surgery: clinical study including examination of antimicrobial prophylaxis. N Engl J Med 278: 117, 1968
PubMed Web of Science ®Google Scholar
Conte, J. E., Jr, Cohen, S. N., Roe, B. B. & Elashoff, R. M.: Antibiotic prophylaxis and cardiac surgery: a prospective double-blind comparison of single-dose versus miltiple-dose regimens. Ann Intern Med 76: 943, 1972
PubMed Web of Science ®Google Scholar
Goldmann, D. A., Hopkins, C. C., Karchmer, A. W., Abel, R. M., McEnany, M. T., Akins, C., Buckley, M. J. & Moellering, R. C., Jr: Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg 73: 470, 1977
PubMed Web of Science ®Google Scholar
Kaiser, A. B., Clayson, K. R., Mulherin, J. L., Jr, Roach, A. C., Allen, T. R., Edwards, W. H. & Dale, W. A.: Antibiotic prophylaxis in vascular surgery. Ann Surg 188: 283, 1978
PubMed Web of Science ®Google Scholar
Pavel, A., Smith, R. L., Ballard, A. & Larsen, I. J.: Prophylactic antibiotics in clean orthopaedic surgery. J Bone Joint Surg 56–A: 777, 1974
Google Scholar
Boyd, R. J., Burke, J. F. & Colton, T.: A double-blind clinical trial of prophylactic antibiotics in hip fractures. J Bone Joint Surg 55–A: 1251, 1973
Web of Science ®Google Scholar
Ericson, C., Lidgren, L. & Lindberg, L.: Cloxacillin in the prophylaxis of postoperative infections of the hip. J Bone Joint Surg 55–A: 808, 1973
Web of Science ®Google Scholar
Carlsson, A. S., Lidgren, L. & Lindberg, L.: Prophylactic antibiotics against early and late deep infections after total replacements. Acta Orthop Scand 48: 405, 1977
PubMedGoogle Scholar
Lett, W. J., Ansbacher, R., Davison, B. L. & Otterson, W. N.: Prophylactic antibiotics for women undergoing vaginal hysterectomy. J Reprod Med 19: 51, 1977
PubMed Web of Science ®Google Scholar
Mendelson, J., Portnoy, J., DeSaint Victor, J. R. & Gelfand, M. M.: Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstet Gynecol 53: 31, 1979
PubMed Web of Science ®Google Scholar
Holman, J. F., McGowan, J. E. & Thompson, J. D. Perioperative antibiotics in major elective gynecologic surgery. South Med J 71: 417, 1978
PubMed Web of Science ®Google Scholar
Roberts, J. M. & Homesley, H. D.: Low-dose carbenicillin prophylaxis for vaginal and abdominal hysterectomy. Obstet Gynecol 52: 83, 1978
PubMed Web of Science ®Google Scholar
Ledger, W. J., Sweet, R. L. & Headington, J. T.: Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. Am J Obstet Gynecol 115: 766, 1973
PubMed Web of Science ®Google Scholar
Breeden, J. T. & Mayo, J. E.: Low dose prophylactic antibiotics in vaginal hysterectomy. Obstet Gynecol 43: 379, 1974
PubMed Web of Science ®Google Scholar
Ohm, M. J. & Galask, R. P.: The effect of antibiotic prophylaxis on patients undergoing vaginal operations. I. The effect on morbidity. Am J Obstet Gynecol 123: 590, 1975
PubMed Web of Science ®Google Scholar
Forney, J. P., Morrow, C. P., Townsend, D. E. and Disaia, P. J. Impact of cephalosporin prophylaxis on conization-vaginal hysterectomy morbidity. Am J Obstet Gynecol 125: 100, 1976
PubMed Web of Science ®Google Scholar
Bivens, M. D., Neufeld, J. & McCarty, W. D.: The prophylactic use of Keflex and Keflin in vaginal hysterectomy. Am J Obstet Gynecol 122: 169, 1975
PubMed Web of Science ®Google Scholar
Grossman, J. H., III, Greco, T. P., Minkin, M. J., Adams, R. L., Hierholzer, W. J. & Andriole, V. T.: Prophylactic antibiotics in gynecologic surgery. Obstet Gynecol 53: 537, 1979
PubMed Web of Science ®Google Scholar
Clarke, J. S., Condon, R. E., Bartlett, J. G., Gorbach, S. L. & Nichols, R. L. Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. Ann Surg 186: 251, 1977
PubMed Web of Science ®Google Scholar
Polk, H. C., Jr & Lopez-Mayor, J. F.: Postoperative wound infection: a prospective study of determinant factors and preventions. Surgery 66: 97, 1969
PubMed Web of Science ®Google Scholar
Gatehouse, D., Dimock, F., Burdon, D. W., Alexander-Williams, J. & Keighley, M. R. B.: Prediction of wound sepsis following gastric operations. Br J Surg 65: 551, 1978
PubMed Web of Science ®Google Scholar
Condon, R. E.: Rational use of prophylactic antibiotics in gastrointestinal surgery. Surg Clin North Am 55: 1309, 1974
Web of Science ®Google Scholar
Keighley, M. R. B., Baddeley, R. M., Burdon, D. W., Edwards, J. A. C., Quoraishi, A. H., Oates, G. D., Watts, G. T. & Alexander-Williams, J.: A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg 62: 275, 1975
PubMed Web of Science ®Google Scholar
Strachan, C. J. L., Black, J., Powis, S. J. A., Waterworth, T. A., Wise, R., Wilkinson, A. R., Burdon, D. W., Severn, M., Mitra, B. & Norcott, H.: Prophylactic use of cephazolin against wound sepsis after cholecystectomy. Br Med J 1: 1254, 1977
PubMed Web of Science ®Google Scholar
Griffiths, D. A., Shorey, B. A., Simpson, R. A., Speller, D. C. E. & Williams, N. B.: Single-dose preoperative antibiotic prophylaxis in gastrointestinal surgery. Lancet 2: 325, 1976
PubMed Web of Science ®Google Scholar
Morran, C., McNaught, W. & McArdle, C. S.: Prophylactic cotrimoxazole in biliary surgery. Br Med J 2: 462, 1978
PubMed Web of Science ®Google Scholar

References

Abrams, H. L. & von Kaenel, W. E.: Medical problems of survivors of nuclear war. N Engl J Med 305; 1226–1232, 1981
PubMed Web of Science ®Google Scholar
Van Bekkum, D. W. & Schotman, E.: Protection from haemopoietic death by shielding versus grafting of bone-marrow. Int J Radiat Biol 25: 361–372 1974
Web of Science ®Google Scholar
Watson, J. G., Powels, R. L., Lawson, D. N., Morgenstern, G. R., Jameson, B., McElwain, T. J. Judson, I., Lumley, H. & Kay, H. E. M.: Cotrimoxazole versus non-absorbable antibiotics in acute leukaemia. Lancet i; 6–9, 1982
Google Scholar
Van der Waaj, D. & Berghuis-de Vries, J. M.: Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg 72: 205–211, 1974
PubMedGoogle Scholar
Sleijfer, D. Th., Mulder, N. H., De Vries-Hospers, H. G., Fidler, V., Nieweg, H. O., Van der Waaij, D. & Van Saene, H. K. F.: Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16, 859–869, 1981
Web of Science ®Google Scholar
Guoit, H. F. L., Van der Meer, J. W. M. & Van Furth, R.: Selective antimicrobial modulation of human microbial flora: Infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Inf Dis. 143, 644–654, 1981
PubMed Web of Science ®Google Scholar
Jehn, U., Ruckdeschell, G., Saner, H., Clemm, Ch. & Wilmans, W.: Vergleichende Studie zum Wert der Selektieven Darmdekontamination (SDD) bei der Behandlung akuter Leukämien. Klin Wochenschr 59, 1093–1099, 1981
PubMedGoogle Scholar
Kurrle, E.: Infektprophylaxe bei der Induktion-Therapie akuter Leukämien. Klin Wochenschr 59; 1085–1089, 1981
Google Scholar
Schimpff, S. C., Young, V. M., Greene, W. H., Vermeulen, G. D., Moody, M. R. & Wiernik, P. H.: Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Int Med 77; 707–714, 1972
PubMed Web of Science ®Google Scholar
Bodey, G. P. & Roderiguez: Infections in cancer patients on a protected environment-prophylactic program. Amer J med 59, 497–504, 1975
PubMed Web of Science ®Google Scholar
Van der Waaij, D., Tielemans-Speltie, T. M. & De Roeck-Houben, A. J.: Infection by and distribution of biotypes of Enterobacteriaceae species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe. Infection 5, 188–194, 1977
PubMed Web of Science ®Google Scholar
Kurrle, E., Bhaduri, S., Krieger, D., Gaus, W., Heimpel, H., Pflieger, R., Arnold, R. & Vanek, E.: Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J Inf Dis 144, 128–136, 1981
PubMed Web of Science ®Google Scholar
Van der Waaij, D., Berghuis-de Vries, J. M. & Lekkerkerk-van der Wees, J. E. C.: Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg 69, 405–411, 1971
PubMedGoogle Scholar
Van der Waaij, D. and Berghuis, J. M. Determination of the colonization resistance of the digestive tract of individual mice. J Hyg 72, 379–387, 1974
PubMedGoogle Scholar
Van der Waaij, D.: The digestive tract in immunocompromized patients: importance of maintaining its resistance to colonization, especially in hospital inpatients and those taking antibiotics. Ciba-Geigy Scientific Publications (in press), 1982
Google Scholar
De Vries-Hospers, H. G., Sleijfer, D. T., Mulder, N. H., Van der Waaij, D., Nieweg, H. O. & Van Saene, H. K. F.: Bacteriological Aspects of Selective Tract as a Method of Infection Prevention in Granulocytopenic Patients. Antimicrob Agents and Chemother, 19, 813–820, 1981
PubMed Web of Science ®Google Scholar
Thijm, H. A. & Van der Waaij, D. The effect of three frequently applied antibiotics on the colonization resistance of the digestive tract in mice. J Hyg 82, 397–405, 1979
PubMedGoogle Scholar
Emmelot, C. H. & Van der Waaij, D.: The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract. J Hyg 84, 331–340
PubMedGoogle Scholar
Wiegersma, N., Jansen, G. & Van der Waaij, D.: Effect of twelve antimicrobial drugs on the colonization resistance of the digestive tract of mice and on endogenous potentially pathogenic bacteria. J Hyg 88, 221–230
PubMedGoogle Scholar
Van der Waaij, D., Aberson, J., Thijm, H. A. & Welling, G. W.: The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice. Infection, 10, 35–40, 1982
PubMed Web of Science ®Google Scholar
Van Saene, H. K. F. & Driessen, L. H. H. M.: Importance of treatment of Staphylococcus aureus carrierstrip in the prevention and therapy of Staphylococcus aureus infections. In: New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance ed. D. van der Waaij, & J. Verhoef), p. 197–206. Excerpta Medica (ICS477), Amsterdam Oxford, 1979
Google Scholar
Senn, J. S., McCulloch, E. A. & Till, J. E.: Comparison of colonyforming ability of normal and leukaemic human marrow in cell culture. Lancet i, 597–598, 1967
Google Scholar
Metcalf, D.: Growth of cells from patients with acute myeloid leukemia. In: Recent results in cancer research. Hemopoietic colonies ed. D. Metcalf), p. 109–115. Springer Verlag, Berlin, Heidelberg, New York, 1976
Google Scholar
Spitze, G., Verma, D. S., Fisher, R., Zander, A., Vellekoop, L., Litam, J. McCredie, K. B. and Dicke, K. A.: The myeloid progenitor cell—its value in predicting hemapoietic recovery after autologous bone marrow transplantation. Blood, 55, 317–323, 1980
PubMed Web of Science ®Google Scholar
Van der Waaij, D.: Colonization resistance of the digestive tract as a major lead in the selection of antibiotics for therapy. In: New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance ed. D. van der Waaij & J. Verhoef), p. 271–280. Excerpta Medica (ICS477) Amsterdam, Oxford 1979
Google Scholar
Van der Waaij, D.: Implications and consequences of antimicrobial therapy for the development and transfer of resistance. In: Proceedings symposium: Evaluation and management of hospital infections ed. R. van Furth), p. 53–60. Martinus Nijhoff, The Hague, 1982
Google Scholar
Hiroshima and Nagasaki: The physical, medical and social effects of the atomic bombings: By: The committee for the compilation of materials on damage caused by the atomic bombs in Hiroshima and Nagasaki. Hutchinson, London, Melbourne, Sydney, Auckland, Johannesburg, 1981
Google Scholar

References

Moser, R. H.: Diseases of medical progress. New Engl J 255: 606, 1956
PubMed Web of Science ®Google Scholar
Barr, D. P.: Hazards of modern diagnosis and therapy—the price we pay. JAMA 159: 1452, 1955
PubMed Web of Science ®Google Scholar
Schimmel, E.: The hazards of hospitalization. Ann Intern Med 60: 100, 1964
PubMed Web of Science ®Google Scholar
Reichel, W.: Complications in the care of five hundred elderly hospitalized patients. J Am Geriatr Soc 13: 973, 1965
PubMed Web of Science ®Google Scholar
Ogilvie, R. I. & Ruedy, J.: Adverse reactions during hospitalization. Can Med Ass J 97: 1445, 1967
PubMed Web of Science ®Google Scholar
McLamb, J. T. & Huntley, R. R.: The hazards of hospitalization. Southern Med J 60: 469, 1967
PubMed Web of Science ®Google Scholar
Steel, K., Gertman, P., Crescenzi, C. & Anderson, J.: Iatrogenic illness on a general medical service at a university hospital. N Engl J Med 304: 638, 1981
PubMed Web of Science ®Google Scholar
Cluff, L., Thornton, G. & Seidl, L.: Studies on the epidemiology of adverse drug reactions. JAMA 188: 144, 1964
Web of Science ®Google Scholar
Karch, F. E. & Lasagna, L.: Adverse drug reactions. A critical review. JAMA 234: 1236, 1975
PubMed Web of Science ®Google Scholar
Green, D. M.: Preexisting conditions, placebo reactions and side effects. Ann Internal Med 60: 255, 1964
PubMed Web of Science ®Google Scholar
Reidenberg, M. M. & Lowenthal, D. I.: Adverse nondrug reactions. N Engl J Med 279: 678, 1968
PubMed Web of Science ®Google Scholar
Thomas, E. T., Evers, W. & Racz, G. B.: Postinfusion phlebitis. Anaesthesia and Analgesia 49: 150, 1970
PubMed Web of Science ®Google Scholar
Illich, I.: Medical Nemesis, 1974. Calder and Boyars
Google Scholar
Beermann, B., Biörck, G. & Groschinsky, M.: Admissions to a medical clinic because of drug intoxication. Läkartidningen 75: 958, 1978
PubMedGoogle Scholar
Hurwitz, N.: Admissions to hospital due to drugs. Br Med J 1: 539, 1969
PubMed Web of Science ®Google Scholar
Caranasos, G., Stewart, R. & Cluff, L.: Drug-induced illness leading to hospitalization. JAMA 228: 713, 1974
PubMed Web of Science ®Google Scholar
Miller, R.: Hospital admissions due to adverse drug reactions. Arch Intern Med 134: 219, 1974
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Positions in Infectious and Parasitic Diseases: Excerpts from the 8th IFIPD Congress Stockholm, June 8–11, 1982

References

References

References

References

Reference

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Positions in Infectious and Parasitic Diseases: Excerpts from the 8th IFIPD Congress Stockholm, June 8–11, 1982

References

References

References

References

Reference

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date